THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
Tax period
2016-10-01 to 2017-09-30
Filed
2018-07-16
IRS object ID
201841979349300869
Schema version
2016v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-07-16T15:40:02-05:00ReturnTs
Tax Period End2017-09-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GRANT THORNTON LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1757 THIRD AVENUE 3RD FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100172013ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-10-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133163817EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE FOUNDATION FOR AIDS RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% BRADLEY JENSENInCareOfNm
Business Name ControlFOUNBusinessNameControlTxt
Phone2128061600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 wall street 13TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100053908ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonBRADLEY JENSENPersonNm
Person TitleASSISTANT TREAS./CFOPersonTitleTxt
Phone2128061703PhoneNum
Signature2018-07-16SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonScott ThompsettPreparerPersonNm
PTINP00741490PTIN
Phone2125990100PhoneNum
Preparation2018-07-16PreparationDt
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1Aids Research Foundation or amfARBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKEVIN FROSTPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 WALL STREET 13TH FLOORAddressLine1Txt
Citynew yorkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10005ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$65,592,839GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.AMFAR.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1983FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionAMFAR IS DEDICATED TO ENDING THE GLOBAL AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body15VotingMembersGoverningBodyCnt
Voting Members Independent15VotingMembersIndependentCnt
Total Employee88TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$58,810,206PYContributionsGrantsAmt
CY Contributions Grants$50,842,378CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$1,108,834PYInvestmentIncomeAmt
CY Investment Income$1,434,528CYInvestmentIncomeAmt
PY Other Revenue-$11,056,842PYOtherRevenueAmt
CY Other Revenue-$11,850,334CYOtherRevenueAmt
PY Total Revenue$48,862,198PYTotalRevenueAmt
CY Total Revenue$40,426,572CYTotalRevenueAmt
PY Grants And Similar Paid$10,349,259PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$12,204,275CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$10,487,770PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$11,102,574CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$854,723PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$746,863CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$5,698,108CYTotalFundraisingExpenseAmt
PY Other Expenses$19,985,556PYOtherExpensesAmt
CY Other Expenses$19,193,671CYOtherExpensesAmt
PY Total Expenses$41,677,308PYTotalExpensesAmt
CY Total Expenses$43,247,383CYTotalExpensesAmt
PY Revenues Less Expenses$7,184,890PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$2,820,811CYRevenuesLessExpensesAmt
Total Assets BOY$80,773,661TotalAssetsBOYAmt
Total Assets EOY$80,221,720TotalAssetsEOYAmt
Total Liabilities BOY$19,134,481TotalLiabilitiesBOYAmt
Total Liabilities EOY$20,491,474TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$61,639,180NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$59,730,246NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMF'S LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH. "ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARCMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$22,602,651ExpenseAmt
Grant$9,179,568GrantAmt
Revenue$0RevenueAmt
DescRESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$4,581,510ExpenseAmt
Grant$2,065,471GrantAmt
Revenue$0RevenueAmt
DescTREAT ASIA: AMFAR'S TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF HIV TREATMENTS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$4,217,812ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescPUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT AIDS-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE BROAD AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR ALSO PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtGrantGrantAmtRevenueRevenueAmtDescDesc
$2,202,676$217,869$0public policy
$1,260,903$741,367$0GMT Initiative
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$3,463,579TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$959,236TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$34,865,552TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtYes (true)CollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document119IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee88EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryTHForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members15GoverningBodyVotingMembersCnt
Independent Voting Member15IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonBRADLEY JENSENPersonNm
Phone2128061703PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 WALL STREET 13TH FLOORAddressLine1Txt
Citynew yorkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100053908ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (39 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Mathilde Krim PhD
Founding Chairman1.00.0Yes (X)Yes (X)$0$0$0
Kenneth Cole
Chairman of the Board1.00.0Yes (X)Yes (X)$0$0$0
Patricia J Matson
Vice Chairman1.00.0Yes (X)Yes (X)$0$0$0
John C Simons
Vice Chairman AND TREASURER1.00.0Yes (X)Yes (X)$0$0$0
Mervyn F Silverman MDMPH
Secretary1.00.0Yes (X)Yes (X)$0$0$0
Arlen H Andelson
Trustee1.00.0Yes (X)$0$0$0
Harry Belafonte
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
David Bohnett
Trustee (NON-VOT.) (Thru 8/17)1.00.0Yes (X)$0$0$0
Zev Braun
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Jonathan S Canno
Trustee1.00.0Yes (X)$0$0$0
Donald Capoccia
Trustee1.00.0Yes (X)$0$0$0
R Martin Chavez PhD
Trustee (Thru 1/2017)1.00.0Yes (X)$0$0$0
Jane B Eisner
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
T Ryan Greenawalt
Trustee (Thru 8/2017)1.00.0Yes (X)$0$0$0
Regan Hofmann
Trustee1.00.0Yes (X)$0$0$0
Michael J Klingensmith
Trustee1.00.0Yes (X)$0$0$0
Kevin McClatchy
Trustee (Thru 8/2017)1.00.0Yes (X)$0$0$0
Michele V McNeill PharmD
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Edward Milstein
Trustee1.00.0Yes (X)$0$0$0
Cindy Rachofsky
Trustee1.00.0Yes (X)$0$0$0
Vincent A Roberti
Trustee1.00.0Yes (X)$0$0$0
Bill Roedy
Trustee1.00.0Yes (X)$0$0$0
Raymond F Schinazi PhD
Trustee1.00.0Yes (X)$0$0$0
Alan D Schwartz
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Diana L Taylor
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Kevin Frost
Chief Executive Officer40.00.0Yes (X)$582,053$0$100,140
Bradley Jensen
Assistant Treasurer, CFO40.00.0Yes (X)$246,513$0$63,826
John F Logan JD PhD
AssT Sec, Vp, GEN COUNSEL40.00.0Yes (X)$239,658$0$31,714
Rowena Johnston
ASST SEC, VP, RESEARCH40.00.0Yes (X)$194,970$0$28,678
Edward Donnelly
Asst Treasurer, Controller40.00.0Yes (X)$156,761$0$25,109
Eric Muscatell
Vice President of Development40.00.0$219,567$0$30,470Yes (X)
Annette Sohn
Vice President, TREAT Asia PGM40.00.0$235,371$0$23,215Yes (X)
AnnMarie Shannahan
Vice President, Public Info.40.00.0$224,984$0$30,789Yes (X)
Gregorio Millet
Vice President, Public Policy40.00.0$187,714$0$27,819Yes (X)
Andrew McInness
Director, Publications40.00.0$160,449$0$57,457Yes (X)
Anthony Ancona
Vice President, Human Resource40.00.0$182,044$0$28,322Yes (X)
Susan Doster
Chief Technology Officer40.00.0$144,866$0$46,025Yes (X)
Bennah Serfaty
Sr Director of CommunicatiON40.00.0$127,459$0$55,087Yes (X)
JONATHAN KEY
DIRECTOR, PHILANTHROPY40.00.0$185,023$0$48,664Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,087,432TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$597,315TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K25IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
AAB PRODUCTION INC
64 ALLEN STREET 5TH FLOORNEW YORKNY10002events production$512,500
JOSH WOODS PRODUCTION
39 WEST 14TH STREET SUITE 504NEW YORKNY10011Events Production$394,500
EIDOLON COMMUNICATIONS INC
15 MAIDEN LANE SUITE 1401NEW YORKNY10038DIRECT MAIL/CONSULT.$313,319
King Company
101 FIFTH AVENUE 8TH FLOORNEW YORKNY10003PUBLIC RELATIONS$226,601
CLARKEBOT INC
33 Fairview TerraceMAPLEWOODNJ07040Art & Graphic Design$148,788
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K10CntrctRcvdGreaterThan100KCnt
Federated Campaigns$207,695FederatedCampaignsAmt
Fundraising$30,056,709FundraisingAmt
Government Grants$11,578,196GovernmentGrantsAmt
All Other Contributions$8,999,778AllOtherContributionsAmt
Noncash Contributions$82,139NoncashContributionsAmt
Total Contributions$50,842,378TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,295,049TotalRevenueColumnAmt
Exclusion$1,295,049ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$59,464TotalRevenueColumnAmt
Exclusion$59,464ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$11,576,947SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$11,437,468SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$139,479SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$139,479TotalRevenueColumnAmt
Exclusion$139,479ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$1,797,050FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$30,056,709ContriRptFundraisingEventAmt
Fundraising Direct Expenses$13,726,531FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$11,929,481TotalRevenueColumnAmt
Exclusion-$11,929,481ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$13,222GrossSalesOfInventoryAmt
Cost Of Goods Sold$2,268CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,954TotalRevenueColumnAmt
Exclusion$10,954ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
LIST RENTALS900099$3,691$3,691
STORE SALES900099$1,250$1,250
MISCELLANEOUS INCOME900099$3,788$3,788
FieldValueIRS element (for citing)
Other Revenue Total$8,729OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$40,426,572TotalRevenueColumnAmt
Exclusion-$10,415,806ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$7,933,673TotalAmt
Program Services$7,933,673ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$4,270,602TotalAmt
Program Services$4,270,602ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,574,035TotalAmt
Program Services$1,873,359ProgramServicesAmt
Management And General$333,721ManagementAndGeneralAmt
Fundraising$366,955FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$6,071,158TotalAmt
Program Services$4,044,015ProgramServicesAmt
Management And General$651,731ManagementAndGeneralAmt
Fundraising$1,375,412FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$353,056TotalAmt
Program Services$226,100ProgramServicesAmt
Management And General$40,805ManagementAndGeneralAmt
Fundraising$86,151FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,577,997TotalAmt
Program Services$1,028,659ProgramServicesAmt
Management And General$240,615ManagementAndGeneralAmt
Fundraising$308,723FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$526,328TotalAmt
Program Services$344,477ProgramServicesAmt
Management And General$62,905ManagementAndGeneralAmt
Fundraising$118,946FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$550,339TotalAmt
Program Services$547,250ProgramServicesAmt
Management And General$3,058ManagementAndGeneralAmt
Fundraising$31FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$199,289TotalAmt
Management And General$199,289ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$105,279TotalAmt
Program Services$105,279ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$746,863TotalAmt
Fundraising$746,863FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$304,037TotalAmt
Management And General$304,037ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,513,792TotalAmt
Program Services$1,002,108ProgramServicesAmt
Management And General$46,649ManagementAndGeneralAmt
Fundraising$465,035FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$374,969TotalAmt
Program Services$347,418ProgramServicesAmt
Management And General$1,088ManagementAndGeneralAmt
Fundraising$26,463FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$74,432TotalAmt
Program Services$47,696ProgramServicesAmt
Management And General$6,182ManagementAndGeneralAmt
Fundraising$20,554FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$297,330TotalAmt
Program Services$237,284ProgramServicesAmt
Management And General$27,409ManagementAndGeneralAmt
Fundraising$32,637FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,368,172TotalAmt
Program Services$1,070,432ProgramServicesAmt
Management And General$122,466ManagementAndGeneralAmt
Fundraising$175,274FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,167,732TotalAmt
Program Services$561,630ProgramServicesAmt
Management And General$6,006ManagementAndGeneralAmt
Fundraising$600,096FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$775,959TotalAmt
Program Services$706,912ProgramServicesAmt
Management And General$10,019ManagementAndGeneralAmt
Fundraising$59,028FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$542,084TotalAmt
Program Services$430,415ProgramServicesAmt
Management And General$49,243ManagementAndGeneralAmt
Fundraising$62,426FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$326,133TotalAmt
Program Services$258,950ProgramServicesAmt
Management And General$29,626ManagementAndGeneralAmt
Fundraising$37,557FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PROGRAM MATERIALS$7,088,724$7,088,724
PROGRAM TECHNICAL SUPPORT$998,963$998,963
POSTAGE & SHIPPING$682,917$342,399$2,911$337,607
PRINTING$669,627$200,795$968$467,864

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$2,153,893TotalAmt
Program Services$1,198,412ProgramServicesAmt
Management And General$544,995ManagementAndGeneralAmt
Fundraising$410,486FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$43,247,383TotalAmt
Program Services$34,865,552ProgramServicesAmt
Management And General$2,683,723ManagementAndGeneralAmt
Fundraising$5,698,108FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$713,656TotalAmt
Program Services$225,466ProgramServicesAmt
Fundraising$488,190FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$21,651,323BOYAmt
EOY$9,608,338EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$323,338BOYAmt
EOY$323,338EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$464,693BOYAmt
EOY$1,054,693EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$9,959,486BOYAmt
EOY$7,565,297EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$575,913BOYAmt
EOY$444,076EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,630,566BOYAmt
EOY$2,895,192EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$7,508,100LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$4,433,600LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$2,976,566BOYAmt
EOY$3,074,500EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$42,064,454BOYAmt
EOY$53,762,394EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$36,797BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,090,525BOYAmt
EOY$1,493,892EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$80,773,661BOYAmt
EOY$80,221,720EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$3,412,592BOYAmt
EOY$3,028,826EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$2,973,966BOYAmt
EOY$3,445,162EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$10,727,662BOYAmt
EOY$11,985,013EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,020,261BOYAmt
EOY$2,032,473EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$19,134,481BOYAmt
EOY$20,491,474EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$58,215,899BOYAmt
EOY$55,835,428EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,060,748BOYAmt
EOY$3,526,335EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$362,533BOYAmt
EOY$368,483EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$61,639,180BOYAmt
EOY$59,730,246EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$80,773,661BOYAmt
EOY$80,221,720EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$2,820,811ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$911,877NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$38,582,579CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$57,556,516CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$56,251,128CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,810,206CurrentTaxYearMinus1YearAmt
Current Tax Year$50,842,378CurrentTaxYearAmt
Total$262,042,807TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$38,582,579CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$57,556,516CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$56,251,128CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,810,206CurrentTaxYearMinus1YearAmt
Current Tax Year$50,842,378CurrentTaxYearAmt
Total$262,042,807TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$2,261,396SubstantialContributorsTotAmt
Public Support Total170$259,781,411PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$755,293CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$804,366CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,652,775CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,316,372CurrentTaxYearMinus1YearAmt
Current Tax Year$1,354,513CurrentTaxYearAmt
Total$5,883,319TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,467,184CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,693,833CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,103,589CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,246,081CurrentTaxYearMinus1YearAmt
Current Tax Year$1,819,001CurrentTaxYearAmt
Total$9,329,688TotalAmt
FieldValueIRS element (for citing)
Total Support$277,255,814TotalSupportAmt
Public Support CY1700.93697PublicSupportCY170Pct
Public Support PY1700.92039PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind
Thirty Thr Pct Suprt Tests PY170Yes (X)ThirtyThrPctSuprtTestsPY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsfalseDirectContactLegislatorsInd
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$371,694OtherActivitiesAmt
Total Lobbying Expenditures$371,694TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind
Form4720 Filed4912 TaxfalseForm4720Filed4912TaxInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLOBBYING EXPENSESFormAndLineReferenceDesc
ExplanationPART II-B THE FOUNDATION FOR AIDS RESEARCH DEVELOPED AN ACTION AGENDA TO END AIDS THAT IDENTIFIED CRITICAL DECISIONS THAT NEED TO BE MADE TO ADVANCE EVIDENCE BASED AIDS POLICIES. WE CREATED A VARIETY OF ISSUE BRIEFS ON TOPICS SUCH AS THE POTENTIAL IMPACT OF VARIOUS BUDGET SCENARIOS ON GLOBAL HEALTH SERVICES, AND POLICY PRIORITIES TO ADDRESS THE HIV EPIDEMIC AMONG GAY MEN IN THE US. THESE ISSUE BRIEFS WERE SHARED WITH CAPITOL HILL STAFF AND MEMBERS OF THE ADMINISTRATION. AMFAR MET REGULARLY WITH STAFF TO MEMBERS OF CONGRESS AND WITH ADMINISTRATION STAFF, AND WE PROVIDED INPUT TO THE ADMINISTRATION ON DEVELOPMENT OF THE PEPFAR BLUEPRINT FOR AN AIDS FREE GENERATION. AMFAR SPONSORED SEVERAL BRIEFINGS ON CAPITOL HILL ON AIDS POLICY AND RESEARCH ISSUES. AMFAR USES THESE BRIEFINGS AS AN EDUCATIONAL TOOL.ExplanationTxt

Schedule D IRS990ScheduleD

Art Public Exhibition Amounts ArtPublicExhibitionAmountsGrp

FieldValueIRS element (for citing)
Assets Included$494,473AssetsIncludedAmt
FieldValueIRS element (for citing)
Held Works ArtHeldWorksArtGrp

Collection Used Other Purposes CollectionUsedOtherPurposesGrp

FieldValueIRS element (for citing)
Collection Used Other PurposesYes (X)CollectionUsedOtherPurposesInd
Other PurposesDonated Items, Inventory etc.OtherPurposesDesc
FieldValueIRS element (for citing)
Solicited Assets SaleYes (true)SolicitedAssetsSaleInd

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$541,231BeginningYearBalanceAmt
Contributions$5,950ContributionsAmt
Investment Earnings Or Losses$45,952InvestmentEarningsOrLossesAmt
End Year Balance$593,133EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$493,036BeginningYearBalanceAmt
Contributions$7,293ContributionsAmt
Investment Earnings Or Losses$40,902InvestmentEarningsOrLossesAmt
End Year Balance$541,231EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$490,979BeginningYearBalanceAmt
Contributions$7,998ContributionsAmt
Investment Earnings Or Losses-$5,941InvestmentEarningsOrLossesAmt
End Year Balance$493,036EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$443,886BeginningYearBalanceAmt
Contributions$6,543ContributionsAmt
Investment Earnings Or Losses$40,550InvestmentEarningsOrLossesAmt
End Year Balance$490,979EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$520,804BeginningYearBalanceAmt
Contributions$3,211ContributionsAmt
Investment Earnings Or Losses$20,742InvestmentEarningsOrLossesAmt
Other Expenditures$100,871OtherExpendituresAmt
End Year Balance$443,886EndYearBalanceAmt
FieldValueIRS element (for citing)
Prmnnt Endowment Balance EOY0.62120PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.37880TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,542,490OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$2,542,490BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$304,826OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$304,826BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,660,784OtherCostOrOtherBasisAmt
Depreciation$4,433,600DepreciationAmt
Book Value$227,184BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$3,074,500TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
LONG TERM LEASE LIABILITY$1,810,442
SECTION 457 RETIREMENT LIABILITY$222,031
FieldValueIRS element (for citing)
Total Liability$2,032,473TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$41,557,266TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$911,877NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$218,817DonatedServicesAndUseFcltsAmt
Revenue Not Reported$1,130,694RevenueNotReportedAmt
Revenue Subtotal$40,426,572RevenueSubtotalAmt
Total Revenue Per Form990$40,426,572TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$43,466,200TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$218,817DonatedServicesUseFcltsAmt
Expenses Not Reported$218,817ExpensesNotReportedAmt
Expenses Subtotal$43,247,383ExpensesSubtotalAmt
Total Expenses Per Form990$43,247,383TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
ENDOWMENTSPART V, LINE 4 AMFAR'S ENDOWMENT FUND IS INTENDED TO FUND THE VARIOUS GENERAL RESEARCH PROGRAMS THE ORGANIZATION SPONSORS.
FIN 48 - INCOME TAXESAMFAR FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND GUIDANCE ON MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE-LIKELY-THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. AMFAR IS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH IT IS SUBJECT TO TAX ON INCOME UNRELATED TO ITS EXEMPT PURPOSE, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE CODE. AMFAR HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. AMFAR HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS.
COLLECTIONS OF ART, HISTORICAL TREASURES, OR OTHER SIMILAR ASSETSPART III, LINE 4 AMFAR HOLDS VARIOUS ITEMS OF JEWELRY, PHOTOGRAPHS AND OTHER ITEMS OF ARTISTIC VALUE THAT HAVE BEEN DONATED TO THE ORGANIZATION FOR SALE AT SPECIAL EVENTS. THE ORGANIZATION HAS MAINTAINED THESE ITEMS IN INVENTORY FOR A FEW YEARS AND IS IN THE PROCESS OF SELLING THEM.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmtOfficesOfficesCntEmployeeEmployeeCnt
Central America and the CaribbeanGrantmakingN/A$49,800
East Asia and the PacificGrantmakingN/A$2,719,032
Europe (Including Iceland and Greenland)GrantmakingN/A$996,920
North AmericaGrantmakingN/A$154,467
South AmericaGrantmakingN/A$240,386
South AsiaGrantmakingN/A$32,811
Sub-Saharan AfricaGrantmakingN/A$77,187
East Asia and the PacificProgram ServicesTHERAPEUTICS,TRAINING$1,731,815117
East Asia and the PacificFundraisingN/A$1,820,696
Europe (Including Iceland and Greenland)FundraisingN/A$8,386,928
South AmericaFundraisingN/A$769,244
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees17SubtotalEmployeesCnt
Total Office1TotalOfficeCnt
Total Employee17TotalEmployeeCnt
Subtotal Spent$16,979,286SubtotalSpentAmt
Total Spent$16,979,286TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (98 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
Caribbean/Central AmericaGMT INITIATIVE AWARDS$25,000wire transfe
Caribbean/Central AmericaGMT INITIATIVE AWARDS$23,000wire transfe
East Asia/PacificBASIC RESEARCH$23,619wire transfe
East Asia/PacificBASIC RESEARCH$499,920wire transfe
East Asia/PacificBASIC RESEARCH$56,378wire transfe
East Asia/PacificBASIC RESEARCH$74,988wire transfe
East Asia/PacificGMT INITIATIVE GRANTS$184,620wire transfe
East Asia/PacificGMT INITIATIVE GRANTS$39,814wire transfe
East Asia/PacificGMT INITIATIVE AWARDS$25,000wire transfe
East Asia/PacificTREAT ASIA$5,893wire transfe
East Asia/PacificTREAT ASIA$7,062wire transfe
East Asia/PacificTREAT ASIA$24,984wire transfe
East Asia/PacificTREAT ASIA$7,500wire transfe
East Asia/PacificTREAT ASIA$7,500wire transfe
East Asia/PacificTREAT ASIA$25,000wire transfe
East Asia/PacificTREAT ASIA$10,346wire transfe
East Asia/PacificTREAT ASIA$5,396wire transfe
East Asia/PacificTREAT ASIA$18,400wire transfe
East Asia/PacificTREAT ASIA$6,622wire transfe
East Asia/PacificTREAT ASIA$12,197wire transfe
East Asia/PacificTREAT ASIA$19,982wire transfe
East Asia/PacificTREAT ASIA$14,025wire transfe
East Asia/PacificTREAT ASIA$15,650wire transfe
East Asia/PacificTREAT ASIA$9,950wire transfe
East Asia/PacificTREAT ASIA$21,044wire transfe
East Asia/PacificTREAT ASIA$16,800wire transfe
East Asia/PacificTREAT ASIA$21,814wire transfe
East Asia/PacificTREAT ASIA$23,714wire transfe
East Asia/PacificTREAT ASIA$22,488wire transfe
East Asia/PacificTREAT ASIA$22,744wire transfe
East Asia/PacificTREAT ASIA$23,670wire transfe
East Asia/PacificTREAT ASIA$21,510wire transfe
East Asia/PacificTREAT ASIA$22,570wire transfe
East Asia/PacificTREAT ASIA$14,200wire transfe
East Asia/PacificTREAT ASIA$22,280wire transfe
East Asia/PacificTREAT ASIA$21,192wire transfe
East Asia/PacificTREAT ASIA$21,234wire transfe
East Asia/PacificTREAT ASIA$5,175wire transfe
East Asia/PacificTREAT ASIA$6,375wire transfe
East Asia/PacificTREAT ASIA$6,075wire transfe
East Asia/PacificTREAT ASIA$5,475wire transfe
East Asia/PacificTREAT ASIA$5,550wire transfe
East Asia/PacificTREAT ASIA$5,250wire transfe
East Asia/PacificTREAT ASIA$243,968wire transfe
East Asia/PacificTREAT ASIA$175,225wire transfe
East Asia/PacificTREAT ASIA$130,587wire transfe
East Asia/PacificTREAT ASIA$9,000wire transfe
East Asia/PacificTREAT ASIA$197,244wire transfe
East Asia/PacificTREAT ASIA$63,024wire transfe
East Asia/PacificTREAT ASIA$41,632wire transfe
East Asia/PacificTREAT ASIA$46,216wire transfe
East Asia/PacificTREAT ASIA$8,206wire transfe
East Asia/PacificTREAT ASIA$9,450wire transfe
East Asia/PacificTREAT ASIA$10,046wire transfe
East Asia/PacificTREAT ASIA$11,575wire transfe
East Asia/PacificTREAT ASIA$11,048wire transfe
East Asia/PacificTREAT ASIA$6,242wire transfe
East Asia/PacificTREAT ASIA$18,423wire transfe
East Asia/PacificTREAT ASIA$7,283wire transfe
East Asia/PacificTREAT ASIA$13,254wire transfe
East Asia/PacificTREAT ASIA$6,966wire transfe
East Asia/PacificTREAT ASIA$7,961wire transfe
East Asia/PacificTREAT ASIA$62,496wire transfe
East Asia/PacificTREAT ASIA$18,682wire transfe
East Asia/PacificTREAT ASIA$16,789wire transfe
East Asia/PacificTREAT ASIA$9,823wire transfe
East Asia/PacificTREAT ASIA$7,972wire transfe
East Asia/PacificTREAT ASIA$6,500wire transfe
East Asia/PacificTREAT ASIA$6,497wire transfe
East Asia/PacificTREAT ASIA$6,500wire transfe
East Asia/PacificTREAT ASIA$6,500wire transfe
East Asia/PacificTREAT ASIA$6,260wire transfe
East Asia/PacificTREAT ASIA$18,750wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$15,000wire transfe
EuropeBASIC RESEARCH$29,990wire transfe
EuropeBASIC RESEARCH$53,332wire transfe
EuropeBASIC RESEARCH$20,833wire transfe
EuropeBASIC RESEARCH$75,000wire transfe
EuropeBASIC RESEARCH$96,645wire transfe
EuropeBASIC RESEARCH$90,009wire transfe
EuropeRESEARCH RSRL$182,141wire transfe
EuropeRESEARCH RSRL$143,824wire transfe
EuropeRESEARCH RSRL$316,203wire transfe
North America (excl USA)BASIC RESEARCH$54,469wire transfe
North America (excl USA)BASIC RESEARCH$99,998wire transfe
South AmericaBASIC RESEARCH$15,000wire transfe
South AmericaGMT INITIATIVE GRANTS$200,386wire transfe
South AmericaGMT INITIATIVE AWARDS$25,000wire transfe
South AsiaTREAT ASIA$7,500wire transfe
South AsiaTREAT ASIA$16,912wire transfe
South AsiaTREAT ASIA$8,399wire transfe
Sub-Saharan AfricaGMT INITIATIVE AWARDS$25,000wire transfe
Sub-Saharan AfricaTREAT ASIA$51,325wire transfe
FieldValueIRS element (for citing)
Total501c3 Org98Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FOREIGN ACTIVITIESPART I, LINE 2 INTERNATIONAL ORGANIZATIONS ARE RECOMMENDED FOR FUNDING BASED UPON THE RESULTS OF COMMUNITY-BASED PEER REVIEW AND/OR PROGRAM STAFF ASSESSMENT OF PROPOSAL MERIT AND ORGANIZATION CAPACITY TO UNDERTAKE PROPOSED PROJECTS THAT ARE CHARITABLE IN PURPOSE. PRE-AWARD DUE-DILIGENCE FOR NEW INTERNATIONAL GRANTEES INCLUDES REVIEW OF ORGANIZATION DOCUMENTS AND REGISTRATIONS TO VERIFY THAT THE ORGANIZATION OPERATES FOR A CHARITABLE PURPOSE AND THAT BASIC CAPACITY FOR PROJECT OVERSIGHT AND GOVERNANCE HAS BEEN ESTABLISHED. ALL INTERNATIONAL GRANTEES ARE REQUIRED TO REPORT SEMI-ANNUALLY ON PROJECT PROGRESS AND EXPENDITURES; CONTINUED REPORTING IS REQUIRED UNTIL SUCH TIME AS GRANT FUNDS ARE EXPENDED IN FULL. REPORTS ARE REVIEWED BY ADMINISTRATIVE AND PROGRAM STAFF. ADDITIONAL OVERSIGHT IS PROVIDED AS NECESSARY BY MEANS OF ONGOING, INFORMAL CONTACT WITH SITES REGARDING PROGRESS AND TECHNICAL ISSUES AND SITE VISITS WHERE FEASIBLE. INTERNATIONAL RESEARCH GRANT RECIPIENTS SUBMIT AN INTERIM AND A FINAL PROGRESS REPORTING ADDITION TO EXPENDITURES REPORTS DUE FOLLOWING THE ENDS OF THE 2ND, 3RD AND FINAL QUARTERS OF THE PERFORMANCE PERIOD.
FOREIGN ACTIVITIESPART I, LINE 3, COLUMN D THE FOUNDATION FOR AIDS RESEARCH CONDUCTS MANY OF ITS GRANT-MAKING PROGRAM SERVICES (SEE PART III OF FORM 990) IN U.S. AND FOREIGN JURISDICTIONS. IN COLUMN D, THE ORGANIZATION HAS REPORTED THE BASIC PROGRAM THESE GRANTS SUPPORT; PLEASE REFER TO PART III FOR MORE INFORMATION ABOUT THESE PROGRAMS/INITIATIVES.
FOREIGN ACTIVITIES - STATUS OF GRANTEESTHE FOUNDATION FOR AIDS RESEARCH SUPPORTS MANY NON-U.S. ORGANIZATIONS IN THE FIGHT AGAINST AIDS AND HIV-RELATED DISEASES. FOR PURPOSES OF SCHEDULE F, PART II, LINE 2 - ALL 98 CHARITIES SUPPORTED ARE PRESUMED TO BE THE EQUIVALENT OF U.S. CHARITIES.

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Solicitation Of Govt GrantsYes (X)SolicitationOfGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)

ActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmt
aab productions INC
events productionfalse$22,385,427$586,480$21,798,947
EIDOLON COMM INC
direct mailfalse$2,149,452$288,370$1,861,082
Donor Services Group LLC
Tele marketingfalse$7,838$31,738-$23,900
Josh Woods Production
events Productionfalse$4,895,395$359,850$4,535,545
FieldValueIRS element (for citing)
Total Gross Receipts$29,438,112TotalGrossReceiptsAmt
Total Retained By Contractors$1,266,438TotalRetainedByContractorsAmt
Total Net To Organization$28,171,674TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1CannesEvent1Nm
Gross Receipts Event1$16,271,745GrossReceiptsEvent1Amt
Charitable Contri Event1$15,787,745CharitableContriEvent1Amt
Gross Revenue Event1$484,000GrossRevenueEvent1Amt
Rent Facility Costs Event1$988,368RentFacilityCostsEvent1Amt
Food And Beverage Event1$299,106FoodAndBeverageEvent1Amt
Entertainment Event1$2,675,173EntertainmentEvent1Amt
Other Direct Expenses Event1$3,084,555OtherDirectExpensesEvent1Amt
Event2DallasEvent2Nm
Gross Receipts Event2$4,406,737GrossReceiptsEvent2Amt
Charitable Contri Event2$4,223,737CharitableContriEvent2Amt
Gross Revenue Event2$183,000GrossRevenueEvent2Amt
Rent Facility Costs Event2$341,192RentFacilityCostsEvent2Amt
Food And Beverage Event2$229,411FoodAndBeverageEvent2Amt
Entertainment Event2$162,780EntertainmentEvent2Amt
Other Direct Expenses Event2$647,270OtherDirectExpensesEvent2Amt
Other Events Total17OtherEventsTotalCnt
Gross Receipts Other Events$11,175,277GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$10,045,227CharitableContriOtherEventsAmt
Gross Revenue Other Events$1,130,050GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events$682,192RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$847,590FoodAndBeverageOtherEventsAmt
Entertainment Other Events$1,264,605EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$2,504,289OthDirectExpnssOtherEventsAmt
Gross Receipts Total$31,853,759GrossReceiptsTotalAmt
Charitable Contributions Tot$30,056,709CharitableContributionsTotAmt
Gross Revenue Total Events$1,797,050GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$2,011,752RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$1,376,107FoodAndBeverageTotalEventsAmt
Entertainment Total Events$4,102,558EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$6,236,114OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$13,726,531DirectExpenseSummaryEventsAmt
Net Income Summary-$11,929,481NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART IFormAndLineReferenceDesc
ExplanationTHE FOUNDATION FOR AIDS RESEARCH ACTUALLY PAID OUT $746,863 IN FUNDRAISING EXPENSES FOR THE YEAR ENDING SEPTEMBER 30, 2017. THIS AMOUNT IS REPORTED ON PART IX, LINE 11(E). FOR PURPOSES OF SCHEDULE G, THE FOUNDATION IS REPORTING ALL AMOUNTS PAID TO THE CONSULTANTS LISTED ON PART I, REGARDLESS OF WHETHER SUCH AMOUNTS WERE PURE FUNDRAISING EXPENSES OR EVENT PRODUCTION COSTS. ON SCHEDULE G, THE TOTAL AMOUNT PAID TO THE ORGANIZATIONS LISTED IS $1,266,438. OF THAT $1,266,438, ONLY $746,863 WAS PAID FOR FUNDRAISING SERVICES, THE REMAINING $519,575 WAS PAID FOR EVENT PRODUCTION SERVICES. IN THE INTERESTS OF CLARITY, THE FOUNDATION WOULD ALSO LIKE TO MAKE CLEAR THAT THE COMPENSATION REPORTED AS HAVING BEEN PAID TO THE PROFESSIONAL FUNDRAISERS REPORTED ON SCHEDULE G IS REPORTED ON A FISCAL YEAR BASIS. SOME OF THOSE SAME FUNDRAISERS ARE REPORTED ON THE FOUNDATION'S TOP 5 HIGHEST PAID INDEPENDENT CONTRACTORS LIST (IN SCHEDULE O). IN COMPLIANCE WITH THE INSTRUCTIONS TO THE FORM 990, COMPENSATION REPORTED FOR PART VII (AND LISTED IN SCHEDULE O) IS REPORTED ON A CALENDAR YEAR BASIS. ACCORDINGLY, AMOUNTS ON PART VII AND SCHEDULE G WILL NOT RECONCILE.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (57 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
University of Washington
4333 Brooklyn Ave NE Box 359472SeattleWA981959472916001537501(c)(3)$22,500BASIC RESEARCH
Oregon Health and Science University
3181 SW Sam Jackson Park RoadPortlandOR97239931176109501(c)(3)$29,970BASIC RESEARCH
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$29,999BASIC RESEARCH
Blood Systems Inc
270 Masonic AvenueSan FranciscoCA941184417860098929501(c)(3)$30,000BASIC RESEARCH
University of Utah
15 North Medical Drive East JMRB 21Salt Lake CityUT841125650876000525501(c)(3)$30,000BASIC RESEARCH
Regents of the University of CA San Fran
3333 California Street Suite 315San FranciscoCA94143946036493501(c)(3)$51,432BASIC RESEARCH
University of Nebraska-Lincoln
151 Whittier Research Center 2200LincolnNE685830861470049123501(c)(3)$30,000BASIC RESEARCH
The Rockefeller University
1230 York AvenueNew YorkNY10065131624158501(c)(3)$93,750BASIC RESEARCH
The George Washington University
2121 I Street NW Suite 601WashingtonDC20052530196584501(c)(3)$67,495BASIC RESEARCH
Beth Israel Deaconess Medical Center
330 Brookline AvenueBostonMA02215042103881501(c)(3)$497,988BASIC RESEARCH
Regents of the University of Ca San Fran
3333 California Street Suite 315San FranciscoCA94143946036493501(c)(3)$500,072BASIC RESEARCH
University of California San Diego
9500 Gilman DriveSan DiegoCA920930679956006144501(c)(3)$100,001BASIC RESEARCH
Case Western Reserve University
10900 Euclid Avenue LC 4930ClevelandOH44106341018992501(c)(3)$100,001BASIC RESEARCH
Case Western Reserve University
10900 Euclid Avenue LC 4930ClevelandOH44106341018992501(c)(3)$100,001BASIC RESEARCH
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$100,001BASIC RESEARCH
Emory University
1599 Clifton RoadAtlantaGA303224250580566256501(c)(3)$100,001BASIC RESEARCH
Johns Hopkins University
733 N Broadway MRB Suite 117BaltimoreMD21205520595110501(c)(3)$100,001BASIC RESEARCH
Regents of the University of CA San Fran
3333 California Street Suite 315San FranciscoCA94143946036493501(c)(3)$19,440BASIC RESEARCH
Boston Medical Center
One Boston Medical Center PlaceBostonMA02118043314093501(c)(3)$75,000BASIC RESEARCH
Yale University
266 Whitney AveNew HavenCT06511060646973501(c)(3)$12,500BASIC RESEARCH
Emory University
1599 Clifton RoadAtlantaGA303224250580566256501(c)(3)$50,000BASIC RESEARCH
The Rockefeller University
1230 York AvenueNew YorkNY10065131624158501(c)(3)$60,000BASIC RESEARCH
The Rockefeller University
1230 York AvenueNew YorkNY10065131624158501(c)(3)$168,790BASIC RESEARCH
Fdn For the National Institutes of Health
9650 Rockville PikeBethesdaMD208143999521986675501(c)(3)$133,334BASIC RESEARCH
University of California San Francisco
3333 California Street Suite 315San FranciscoCA94143946036493501(c)(3)$100,000BASIC RESEARCH
University of Washington
4333 Brooklyn Avenue NE Box 35947SeattleWA981959472916001537501(c)(3)$133,333BASIC RESEARCH
Yale University
266 Whitney AveNew HavenCT06511060646973501(c)(3)$133,334BASIC RESEARCH
University of Massachusetts Medical School
373 Plantation StreetWorcesterMA016052377043167352501(c)(3)$133,334BASIC RESEARCH
Johns Hopkins University
733 N Broadway MRB Suite 117BaltimoreMD21205520595110501(c)(3)$132,962BASIC RESEARCH
The J David Gladstone Institutes
1650 Owens StreetSan FranciscoCA94158237203666501(c)(3)$75,000BASIC RESEARCH
The J David Gladstone Institutes
1650 Owens StreetSan FranciscoCA94158237203666501(c)(3)$75,000BASIC RESEARCH
Columbia University
630 West 168th St Box 49New YorkNY10032135598093501(c)(3)$74,523BASIC RESEARCH
Boston Children's Hospital
3 Blackfan Circle Room 3082BostonMA02115042774441501(c)(3)$68,565BASIC RESEARCH
University of Washington
4333 Brooklyn Avenue NE Box 35947SeattleWA981959472916001537501(c)(3)$99,989BASIC RESEARCH
University of California Los Angeles
11000 Kinross Avenue Suite 211Los AngelesCA90095956006143501(c)(3)$100,000BASIC RESEARCH
Trustees of the University of Pennsylvania
3451 Walnut Street P-221 FranklinPhiladelphiaPA191046250231352685501(c)(3)$100,000BASIC RESEARCH
Mayo Clinic College of Medicine
200 First Street SWRochesterMN55905416011702501(c)(3)$25,000BASIC RESEARCH
Oregon Health and Science University
3181 SW Sam Jackson Park RoadPortlandOR97239931176109501(c)(3)$24,993BASIC RESEARCH
Boston University School of Medicine
650 Albany St EBRC 640BostonMA02118043314093501(c)(3)$24,999BASIC RESEARCH
The George Washington University
2121 I Street NW Suite 601WashingtonDC200520086530196584501(c)(3)$24,999BASIC RESEARCH
Fred Hutchinson Cancer Research Center
1100 Fairview Ave NSeattleWA98109237156071501(c)(3)$24,999BASIC RESEARCH
University of Maryland at Baltimore
725 Lombard Street Room S615BaltimoreMD21201526002033501(c)(3)$25,000BASIC RESEARCH
Fred Hutchinson Cancer Research Center
1100 Fairview Ave NSeattleWA98109237156071501(c)(3)$24,999BASIC RESEARCH
International AIDS Vaccine Initiative
125 Broad Street 9th FloorNew YorkNY10004133870223501(c)(3)$24,921BASIC RESEARCH
Swarthmore College
500 College AvenueSwarthmorePA19081231352683501(c)(3)$13,333BASIC RESEARCH
Johns Hopkins University
733 N Broadway MRB Suite 117BaltimoreMD21205520595110501(c)(3)$190,885GMT INITIATIVE GRANTS
New Venture Fund
120 Connecticut Avenue NW Ste 300WashingtonDC20036205806345501(c)(3)$200,000PREVENTION SCIENCE OUTREACH
New Venture Fund
1201 Connecticut Avenue NW Suite 30WashingtonDC20036205806345501(c)(3)$300,000PREVENTION SCIENCE OUTREACH
Johns Hopkins University
733 N Broadway MRB Suite 117BaltimoreMD21205520595110501(c)(3)$20,000PUBLIC POLICY
Georgetown University
600 New Jersey AvenueWashingtonDC20057530196603501(c)(3)$47,928PUBLIC POLICY
AIDS Vaccine Advocacy Coalition (AVAC)
423 West 127 street 4 floorNYNY10027943240841501(c)(3)$49,999PUBLIC POLICY
Johns Hopkins University
733 N Broadway MRB Suite 117BaltimoreMD21205520595110501(c)(3)$99,942PUBLIC POLICY
University of California San Francisco
3333 California Street Suite 315San FranciscoCA94143946036493501(c)(3)$2,773,654RESEARCH RSRL
Harvard University
29 Oxford StreetCambridgeMA02138042103580501(c)(3)$210,652RESEARCH RSRL
Regents of the University of Minnesota
200 Oak Street SE Suite 450MinneapolisMN554552070416007513501(c)(3)$76,800RESEARCH RSRL
Johns Hopkins University
733 N Broadway MRB Suite 117BaltimoreMD21205520595110501(c)(3)$121,644TREAT ASIA
Massachusetts General Hospital
101 Huntington Ave Suite 300BostonMA02199042697983501(c)(3)$45,000TREAT ASIA
FieldValueIRS element (for citing)
Total501c3 Org57Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGRANTS AND ASSISTANCEFormAndLineReferenceDesc
ExplanationPART I, LINE 2 AMFAR PROVIDES GRANTS AND FELLOWSHIPS TO INDEPENDENT NOT-FOR-PROFIT ORGANIZATIONS THROUGH A PEER-REVIEW PROCESS. GRANT APPLICATIONS ARE FIRST REVIEWED BY THE FOUNDATION'S VOLUNTEER SCIENTIFIC ADVISORY COMMITTEE, WHICH COMPRISES RECOGNIZED EXPERTS IN THE MEDICAL, SCIENTIFIC, AND SOCIAL SCIENCES DISCIPLINES RELEVANT TO HIV AND AIDS. THE SCIENTIFIC ADVISORY COMMITTEE THEN SENDS ITS EVALUATIONS TO ONE OF THE THREE COMMITTEES (RESEARCH, GLOBAL INITIATIVES OR PUBLIC POLICY) OF THE FOUNDATION'S PROGRAM BOARD, WHICH SERVES IN AN ADVISORY CAPACITY TO THE BOARD OF TRUSTEES. AFTER A PROGRAM COMMITTEE HAS COMPLETED ITS REVIEW OF THE APPLICATIONS, IT PRESENTS ITS FUNDING RECOMMENDATIONS TO AMFAR'S EXECUTIVE COMMITTEE AND/OR THE FULL BOARD OF TRUSTEES FOR FINAL APPROVAL AND FUNDING AUTHORIZATION. GRANTS AND FELLOWSHIPS ARE PAYABLE OVER A ONE-TO-THREE-YEAR PERIOD, AND ARE REVOCABLE AT AMFAR'S OPTION IF THE RECIPIENT'S PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE TERMS OF THE GRANT OR FELLOWSHIPS. IN CERTAIN CASES, THE ACTUAL AMOUNTS PAID UNDER GRANTS AND FELLOWSHIP AWARDS MAY BE LESS THAN THE ORIGINAL AWARD IF THE RECIPIENT DOES NOT USE THE FULL AMOUNT AWARDED. THEREFORE, A RESERVE FOR UNEXPENDED GRANTS AND FELLOWSHIPS HAS BEEN RECORDED. SUBAWARDS ARE GRANTS AWARDED TO NOT-FOR-PROFIT ORGANIZATIONS TO SUPPORT THE COSTS OF COLLABORATION AND PARTICIPATION IN HIV/AIDS-RELATED RESEARCH PROJECTS FOR WHICH AMFAR HAS SECURED RESTRICTED FUNDS. SUBAWARDS ARE PAYABLE OVER A ONE-YEAR PERIOD, ALTHOUGH ADVANCE PAYMENTS, IN FULL OR IN PART, MAY BE ISSUED FOLLOWING EXECUTION OF THE SUBAWARD AGREEMENT. SUBAWARDS ARE CONTINGENT UPON THE AVAILABILITY OF FUNDS AND ARE REVOCABLE IF THE RECIPIENTS' PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE SUBAWARD TERMS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Kevin Frost
Chief Executive Officer$391,601$0$100,000$0$90,452$0$36,550$0$63,590$0$682,193$0$3,582$0
Bradley Jensen
Assistant Treasurer, CFO$246,513$0$0$0$0$0$17,923$0$45,903$0$310,339$0$0$0
John F Logan JD PhD
AssT Sec, Vp, GEN COUNSEL$239,658$0$0$0$0$0$16,765$0$14,949$0$271,372$0$0$0
Rowena Johnston
ASST SEC, VP, RESEARCH$194,970$0$0$0$0$0$13,729$0$14,949$0$223,648$0$0$0
Edward Donnelly
Asst Treasurer, Controller$156,761$0$0$0$0$0$11,405$0$13,704$0$181,870$0$0$0
Eric Muscatell
Vice President of Development$219,567$0$0$0$0$0$15,521$0$14,949$0$250,037$0$0$0
Annette Sohn
Vice President, TREAT Asia PGM$235,371$0$0$0$0$0$16,475$0$6,740$0$258,586$0$0$0
AnnMarie Shannahan
Vice President, Public Info.$224,984$0$0$0$0$0$15,840$0$14,949$0$255,773$0$0$0
Gregorio Millet
Vice President, Public Policy$187,714$0$0$0$0$0$13,366$0$14,453$0$215,533$0$0$0
Andrew McInness
Director, Publications$160,449$0$0$0$0$0$11,554$0$45,903$0$217,906$0$0$0
Anthony Ancona
Vice President, Human Resource$182,044$0$0$0$0$0$12,793$0$15,529$0$210,366$0$0$0
Susan Doster
Chief Technology Officer$144,866$0$0$0$0$0$10,596$0$35,429$0$190,891$0$0$0
Bennah Serfaty
Sr Director of CommunicatiON$127,459$0$0$0$0$0$9,184$0$45,903$0$182,546$0$0$0
JONATHAN KEY
DIRECTOR, PHILANTHROPY$185,023$0$0$0$0$0$13,235$0$35,429$0$233,687$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceCOMPENSATIONFormAndLineReferenceDesc
ExplanationPART I, LINE 4 CHIEF EXECUTIVE OFFICER, KEVIN FROST, PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. IN CALENDAR YEAR 2016, AMFAR CONTRIBUTED $85,000 INTO MR. FROST'S NON-QUALIFIED RETIREMENT PLAN. THIS AMOUNT IS NOT REPORTED IN SCHEDULE J, PART II, COLUMN (C) BECAUSE THE CONTRIBUTED AMOUNT WAS DISTRIBUTED TO MR. FROST WITHIN THE SAME CALENDAR YEAR. INCLUDED IN SCHEDULE J COLUMN (B)(III) IS MR. FROST'S 2016 EMPLOYER-FUNDED 457(F) CONTRIBUTION OF $85,000 PLUS PAYOUTS OF PREVIOUSLY CONTRIBUTED EMPLOYER-FUNDED 457(F) CONTRIBUTIONS (AND EARNINGS THEREON). IN SCHEDULE J, PART II, COLUMN (F), AMFAR IS REPORTING $3,582 OF 457(F) CONTRIBUTIONS THAT WERE RECORDED AS DEFERRED COMPENSATION ON A PREVIOUSLY FILED FORM 990.ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution13ContributionCnt
Noncash Contributions Rpt F990$82,139NoncashContributionsRptF990Amt
Method Of Determining Revenuessales priceMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceFORM 990, SCHEDULE M, LINE 31FormAndLineReferenceDesc
ExplanationTO THE EXTENT THAT AMFAR RECEIVES NON-STANDARD CONTRIBUTIONS, THE ORGANIZATION'S POLICY IS TO LIQUIDATE THOSE ITEMS INTO CASH FOR EVENTUAL USE IN SUPPORT OF THE ORGANIZATION'S MISSION.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PROGRAM SERVICE ACCOMPLISHMENTS (1)LINE 4A: RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. AMFAR FELLOWSHIPS ALLOW TALENTED YOUNG RESEARCHERS TO CONDUCT ORIGINAL INVESTIGATIONS UNDER THE GUIDANCE OF EXPERIENCED SCIENTISTS, HELPING TO ENSURE THE LONG-TERM VITALITY OF AIDS RESEARCH. NEW GRANTS AND FELLOWSHIPS GRANTS AND FELLOWSHIPS ARE AWARDED THROUGH A RIGOROUS PROCESS OF PEER REVIEW BY A TEAM OF INDEPENDENT HIV/AIDS EXPERTS DRAWN LARGELY FROM THE VOLUNTEER SCIENTISTS ON AMFARS SCIENTIFIC ADVISORY COMMITTEE. GUIDED BY ITS SCIENTIFIC ADVISORS AND WITH THE APPROVAL OF ITS BOARD OF TRUSTEES, AMFAR PURSUES A STRATEGIC RESEARCH PLAN THAT FOCUSES ON THE PURSUIT OF A CURE FOR HIV. COUNTDOWN TO A CURE FOR AIDS IN 2015, AMFAR ANNOUNCED A $100 MILLION INVESTMENT STRATEGY TO SUPPORT ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE, WHICH IS AIMED AT DEVELOPING THE SCIENTIFIC BASIS FOR A CURE BY 2020. THE STRATEGY REPRESENTS AN UNPRECEDENTED EXPANSION OF AMFARS GRANT MAKING AND IS DESIGNED TO PROVIDE SUPPORT TO ANY SCIENTIST OR TEAM OF INVESTIGATORS FOR ANY RESEARCH IDEA WITH THE POTENTIAL TO ADVANCE THE SEARCH FOR A CURE, AT ANY STAGE OF ITS DEVELOPMENT. IT IS STRUCTURED TO PROVIDE SUSTAINED SUPPORT FOR A WIDE RANGE OF STUDIES THAT ADVANCE BOTH EMERGING AND ESTABLISHED IDEAS. THE STRATEGY COMPRISES THE FOLLOWING COMPONENTS: - AMFAR INSTITUTE FOR HIV CURE RESEARCH ESTABLISHED IN 2015 WITH A $20 MILLION GRANT OVER FIVE YEARS TO THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE INSTITUTE IS THE CORNERSTONE OF AMFARS CURE RESEARCH. - INNOVATION GRANTS THESE TWO-YEAR AWARDS OF UP TO $200,000 EACH ENABLE RESEARCHERS TO TEST INNOVATIVE IDEAS SUPPORTED BY LIMITED PRELIMINARY DATA. - IMPACT GRANTS THESE GRANTS OF UP TO $2 MILLION EACH OVER FOUR YEARS SUPPORT THE IN-DEPTH DEVELOPMENT OF CONCEPTS ALREADY UNDERPINNED BY PRELIMINARY DATA SHOWING GENUINE POTENTIAL FOR ACHIEVING A CURE. - INVESTMENT GRANTS AIMED AT RECRUITING THE EXPERIENCE AND EXPERTISE OF SCIENTISTS FROM OUTSIDE THE FIELD OF HIV, THESE $1 MILLION GRANTS ARE AWARDED OVER A FOUR-YEAR PERIOD. GRANTEES MAY HAVE EXPERTISE IN FIELDS SUCH AS CANCER, NEUROSCIENCE, OR INFLAMMATORY DISEASE THAT CAN DIRECTLY INFORM EFFORTS TO CURE HIV. - ARCHE LAUNCHED IN 2010, THE AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION, OR ARCHE, SUPPORTS COLLABORATIVE TEAMS OF SCIENTISTS IN THE U.S. AND AROUND THE WORLD WORKING ON A RANGE OF HIV CURE STRATEGIES. - OPPORTUNITY FUND THIS FUNDING MECHANISM ENABLES AMFAR TO RESPOND QUICKLY TO EMERGING AND UNFORESEEN RESEARCH OPPORTUNITIES. SINCE LAUNCHING THE COUNTDOWN TO A CURE FOR AIDS INITIATIVE, AMFAR HAS AWARDED 58 COUNTDOWN GRANTS TOTALING MORE THAN $41 MILLION TO SUPPORT RESEARCH CONDUCTED BY 222 SCIENTISTS WORKING AT 74 INSTITUTIONS IN 10 COUNTRIES. INNOVATION GRANTS IN JULY 2017, AMFAR AWARDED $1.2 MILLION TO SIX RESEARCHERS WHO ARE EXPLORING MECHANISMS OF HIV PERSISTENCE AND THE POTENTIAL FOR VIRAL ERADICATION. THESE "INNOVATION" GRANTS ARE DESIGNED TO TEST AND ADVANCE PIONEERING IDEAS IN THE EARLY STAGES OF THEIR DEVELOPMENT. FOR INSTANCE, DR. ANDREW BADLEY, FROM THE MAYO CLINIC COLLEGE OF MEDICINE IN ROCHESTER, MN, WILL TEST WHETHER IXAZOMIB, A DRUG CURRENTLY USED TO TREAT THE BLOOD CANCER MULTIPLE MYELOMA, CAN REDUCE THE SIZE OF THE LATENT HIV RESERVOIR IN THE BODY, WHILE DR. JOSHUA SCHIFFER, FROM FRED HUTCHINSON CANCER RESEARCH CENTER IN SEATTLE, WILL TEST A DRUG NORMALLY USED TO PREVENT ORGAN TRANSPLANT REJECTION FOR ITS POTENTIAL TO ELIMINATE THE RESERVOIR COMPLETELY. ADDITIONALLY, DRS. ANDREW HENDERSON, FROM BOSTON UNIVERSITY SCHOOL OF MEDICINE AND FABIO ROMERIO, FROM THE UNIVERSITY OF MARYLAND IN BALTIMORE, ARE EXPLORING A CURE STRATEGY KNOWN AS "BLOCK AND LOCK", WHICH AIMS TO SILENCE HIV AND PREVENT ITS RE-EMERGENCE WHEN ANTIRETROVIRAL THERAPY IS STOPPED. AT THE GEORGE WASHINGTON UNIVERSITY IN WASHINGTON, D.C., DR. BRAD JONES AIMS TO DEVELOP A NEW CLASS OF BROADLY NEUTRALIZING ANTIBODIES TO ELIMINATE THE CONSTRAINTS CAUSED BY THE GENETIC DIFFERENCES BETWEEN PEOPLE. THE GOAL IS TO INCREASE THE NUMBER OF PEOPLE IN WHOM BROADLY NEUTRALIZING ANTIBODIES ARE ABLE TO FIND AND KILL HIV-INFECTED CELLS. AND TO BETTER UNDERSTAND HOW "THE BERLIN PATIENT" WAS CURED OF HIV, DR. BENJAMIN BURWITZ, FROM OREGON HEALTH AND SCIENCE UNIVERSITY IN PORTLAND, PLANS TO GENERATE A MONKEY MODEL LACKING THE PROTEIN CCR5, THE PRIMARY MEANS BY WHICH MOST TYPES OF HIV INFECT CELLS. BROWN WAS CURED AFTER RECEIVING A STEM CELL TRANSPLANT FROM A DONOR WITH A CCR5 MUTATION. INVESTMENT GRANTS IN FEBRUARY 2017, AMFAR ANNOUNCED A NEW ROUND OF INVESTMENT GRANTS, TOTALING $1.2 MILLION, TO SUPPORT SIX RESEARCH PROJECTS THAT ENLIST THE HELP OF BIOENGINEERS TO OVERCOME THE MAIN BARRIER TO A CURE: LATENT HIV RESERVOIRS. FOR EXAMPLE, ONE PAIR OF RESEARCHERS - DRS. TIMOTHY HENRICH, OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (UCSF), AND THE AMFAR INSTITUTE FOR HIV CURE RESEARCH, AND BIOENGINEER UTKAN DEMIRCI FROM STANFORD - AIM TO APPLY MAGNETIC LEVITATION OF SINGLE CELLS TO IDENTIFY AND CHARACTERIZE HIV RESERVOIRS. ANOTHER PAIR - DRS. HUI ZHANG AND WEIMING YANG OF JOHNS HOPKINS UNIVERSITY IN BALTIMORE - ARE USING MASS SPECTROMETRY TO IDENTIFY MOLECULES ON THE SURFACE OF CELLS THAT DIFFERENTIATE LATENT RESERVOIRS FROM UNINFECTED CELLS. AND A THIRD - DRS. PRITI KUMAR AND MARK SALTZMAN OF YALE UNIVERSITY IN NEW HAVEN, CT - ARE EXPLORING A NOVEL GENE-EDITING APPROACH USING A CELL'S MACHINERY TO ELIMINATE HIV RESERVOIRS. ARCHE (AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION) IN JULY 2017, AMFAR AWARDED MORE THAN $2.3 MILLION IN ARCHE GRANTS TO SEVEN TEAMS OF RESEARCHERS WORKING ON GENE THERAPY-BASED APPROACHES TO CURING HIV. WHILE PHARMACOLOGICAL AND IMMUNOLOGICAL APPROACHES REMAIN THE DOMINANT CURE STRATEGIES, THE CASE OF THE "BERLIN PATIENT" POINTS TO THE PROMISE OF GENE THERAPY. THE GRANTEES ARE: DR. HILDEGARD BNING OF HANNOVER MEDICAL SCHOOL, GERMANY; DR. KEITH JEROME OF THE UNIVERSITY OF WASHINGTON, SEATTLE; DR. HANS-PETER KIEM OF FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE; DR. SCOTT KITCHEN OF UCLA; DR. YASUHIRO TAKEUCHI OF UNIVERSITY COLLEGE LONDON; DR. DREW WEISSMAN OF UNIVERSITY OF PENNSYLVANIA IN PHILADELPHIA; AND DR. RICHARD WYATT OF THE SCRIPPS RESEARCH INSTITUTE IN LA JOLLA, CA. THE RESEARCHERS ARE PURSUING PROJECTS AIMED AT: DESIGNING AND REFINING VECTORS THAT CAN ACCURATELY TARGET THE CELLS THAT MAKE UP THE RESERVOIR AND REGIONS SUCH AS THE LYMPH NODES, WHERE THE RESERVOIR CELLS TEND TO BE CONCENTRATED; USING CAR T CELLS, WHICH HAVE SHOWN REMARKABLE PROMISE IN CLEARING SOME TYPES OF CANCER, AS A POTENTIAL MEANS OF KILLING HIV-INFECTED CELLS; AND EXPLORING THE POTENTIAL OF USING VIRAL AND NON-VIRAL DELIVERY MECHANISMS TO DELIVER EMERGING TYPES OF GENETIC SCISSORS THAT COULD CUT THE VIRUS OUT OF HUMAN DNA. MATHILDE KRIM FELLOWSHIPS IN OCTOBER 2016, AMFAR ANNOUNCED THE RECIPIENTS OF THE MATHILDE KRIM FELLOWSHIPS IN BASIC BIOMEDICAL RESEARCH, WHICH SUPPORT BRIGHT YOUNG SCIENTISTS SEEKING SOLUTIONS TO HIV/AIDS. THE SIX KRIM FELLOWS - DR. AMY CHUNG OF THE UNIVERSITY OF MELBOURNE IN AUSTRALIA; DR. DANIELA FERA OF BOSTON CHILDRENS HOSPITAL; DR. MARIT VAN GILS OF THE ACADEMIC MEDICAL CENTER OF THE UNIVERSITY OF AMSTERDAM IN THE NETHERLANDS; DRS. JUDD HULTQUIST AND ANAND PAI OF THE J. DAVID GLADSTONE INSTITUTES IN SAN FRANCISCO; AND DR. DANIEL ROSENBLOOM OF COLUMBIA UNIVERSITY IN NEW YORK - WERE EACH AWARDED APPROXIMATELY $150,000 OVER TWO YEARS.
PROGRAM SERVICE ACCOMPLISHMENTS (1) CONT.PUBLISHED RESEARCH RESEARCH STUDIES MAKE THE GREATEST IMPACT ON THE HIV FIELD AND ON THE BROADER SCIENTIFIC COMMUNITY WHEN THEY ARE PUBLISHED IN SCIENTIFIC JOURNALS. IN FY2017, 52 SCIENTIFIC PUBLICATIONS RESULTED FROM AMFAR-FUNDED RESEARCH. EXAMPLES INCLUDE: UNDERSTANDING EXACTLY HOW THE 'BERLIN PATIENT' WAS CURED THE "BERLIN PATIENT" - TIMOTHY BROWN - REMAINS THE FIRST AND ONLY PERSON KNOWN TO HAVE BEEN CURED OF HIV. DIAGNOSED WITH LEUKEMIA, HE RECEIVED A STEM CELL TRANSPLANT FROM A DONOR WITH A RARE GENETIC MUTATION CONFERRING RESISTANCE TO HIV INFECTION. IN THE JULY 2017 ISSUE OF JAIDS, AMFAR-FUNDED SCIENTIST DR. SHARON LEWIN AND COLLEAGUES REPORTED ON THREE CASES OF HIV-INFECTED INDIVIDUALS WHO RECEIVED STEM CELL TRANSPLANTS FROM DONORS WITHOUT THE MUTATION. ALL THREE HAD UNDETECTABLE VIRAL LOADS ON ANTIRETROVIRAL THERAPY (ART) PRIOR TO THE TRANSPLANT AND WERE MAINTAINED ON ART POST-TRANSPLANT. THE NUMBER OF HIV ANTIBODIES DECREASED IN ALL OF THE PATIENTS, SUGGESTING THERE WAS LESS VIRUS. HOWEVER, IN BROWNS CASE, THE ANTIBODIES DISAPPEARED COMPLETELY. ALL THREE ALSO HAD SUBSTANTIAL REDUCTIONS IN THE SIZE OF LATENT RESERVOIRS. THE CASES CONFIRM THE ABILITY OF A STEM CELL TRANSPLANT TO PROFOUNDLY REDUCE THE SIZE OF THE HIV RESERVOIR AND THE LIKELIHOOD THAT THE MUTATION PLAYED A MAJOR ROLE IN BROWNS CURE. INJECTION OF SPECIFIC ANTIBODIES MAY REDUCE HIV VIRAL LOAD IN THE AUGUST 2017 ISSUE OF VIROLOGY, AMFAR-FUNDED SCIENTIST DR. DAN BAROUCH OF THE CENTER FOR VIROLOGY AND VACCINE RESEARCH AT BETH ISRAEL DEACONESS MEDICAL CENTER IN BOSTON AND COLLEAGUES DETAILED THEIR EXPERIMENTS USING A PASSIVE IMMUNIZATION APPROACH - INJECTING ANTIBODIES DIRECTLY INTO THE PATIENT - TO EXPLORE THE POTENTIAL ROLE OF ANTIBODIES IN CURING HIV INFECTION. BAROUCH AND ASSOCIATES TESTED TWO ANTIBODIES IN 18 MONKEYS INFECTED WITH SHIV, A COMBINATION OF HIV AND SIV (THE MONKEY FORM OF THE VIRUS). BOTH REDUCED THE VIRAL LOAD IN THE MONKEYS. THE RESEARCHERS ALSO FOUND SIGNIFICANTLY REDUCED LEVELS OF SHIV DNA IN THE BLOOD TWO WEEKS AFTER THE ANTIBODIES WERE ADMINISTERED; IN THE LYMPH NODES, SHIV DNA DROPPED MARKEDLY AFTER 10 WEEKS. THE AUTHORS CONCLUDED THAT PASSIVE IMMUNIZATION USING THESE ANTIBODIES COULD, UNDER THE RIGHT CONDITIONS, ERADICATE THE HIV RESERVOIR. USING GROUNDBREAKING CAR-T CANCER THERAPY TO CURE HIV HIV RESEARCH PLAYED A CRITICAL ROLE IN THE DEVELOPMENT OF KYMRIAH, THE FDAS FIRST APPROVED GENE THERAPY TREATMENT FOR CANCER. THE CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPY INVOLVES MODIFYING A PATIENTS OWN T CELLS TO SEEK AND DESTROY CANCER CELLS. IN THE SEPTEMBER 2017 ISSUE OF THE JOURNAL TRANSLATIONAL RESEARCH, AMFAR-FUNDED SCIENTIST DR. SCOTT KITCHEN AND COLLEAGUES FROM THE UNIVERSITY OF CALIFORNIA, LOS ANGELES, NOTED THAT THE FIRST CAR T CELLS USED IN CLINICAL TRIALS WERE DESIGNED TO TREAT HIV. HOWEVER, UNLIKE CANCER, HIV CAN ATTACK THE VERY CAR T CELLS ADMINISTERED TO FIGHT THE INFECTION. KITCHEN AND ASSOCIATES DISCUSSED SEVERAL NOVEL APPROACHES TO ENHANCE THE ACTIVITY OF ANTI-HIV CAR T CELLS AND TO PROTECT THEM AGAINST INFECTION, INCLUDING REMOVING, THROUGH GENETIC ENGINEERING, THE PRIMARY HIV CO-RECEPTOR CCR5, AND USING A COMBINATION APPROACH TO KILL INFECTED CELLS AND ELIMINATE LATENT HIV RESERVOIRS. HIV CURE SUMMIT IN DECEMBER 2016, AMFAR HELD ITS THIRD ANNUAL HIV CURE SUMMIT AT UCSF, WHERE THE AMFAR INSTITUTE FOR HIV CURE RESEARCH IS BASED. LEADING AMFAR-FUNDED CURE RESEARCHERS DETAILED THEIR PROGRESS AND DISCUSSED THE SCIENTIFIC CHALLENGES THAT CONTINUE TO STAND IN THE WAY OF A CURE. DR. PETER HUNT REPORTED ON THE EFFORTS OF HIS TEAM TO CHART, OR PINPOINT, THE PRECISE LOCATIONS OF THE RESERVOIR USING A "FACIAL RECOGNITION SOFTWARE" KNOWN AS CYTOF. DR. WARNER GREENE DISCUSSED THE "SHOCK-AND- KILL" APPROACH TO ERADICATING HIV: FINDING AGENTS THAT CAN EFFECTIVELY "SHOCK" LATENT VIRUS OUT OF ITS HIDING PLACE SO THAT IT CAB BE "KILLED" BY THE IMMUNE SYSTEM OR INTERVENTIONS SUCH AS A THERAPEUTIC VACCINE OR BROADLY NEUTRALIZING ANTIBODIES. DR. SATISH PILLAI TALKED ABOUT THE MULTIPLE CHALLENGES INHERENT IN DETERMINING EXACTLY HOW MUCH VIRUS IS IN THE PERSISTENT HIV RESERVOIR. HE AND HIS COLLEAGUES ARE DEVELOPING HIGHLY SENSITIVE TOOLS THAT ARE MORE EFFECTIVE AT IDENTIFYING TINY AMOUNTS OF RESIDUAL VIRUS. AND DR. STEVEN DEEKS PROVIDED AN UPDATE ON HIS WORK TO TAKE THE EXPERIMENTAL INTERVENTIONS DEVELOPED BY INSTITUTE RESEARCHERS AND TEST THEM IN CLINICAL TRIALS. HIV RESEARCH SUMMIT IN BRAZIL IN A COMMUNITY EDUCATION INITIATIVE, AMFAR HOSTED AN HIV RESEARCH SUMMIT AT THE UNIVERSITY OF SO PAULO, BRAZIL, IN MARCH 2017, BRINGING TOGETHER 250 COMMUNITY MEMBERS, MEDICAL STUDENTS, HEALTHCARE PROFESSIONALS, AND REPRESENTATIVES FROM 10 SO PAULO-BASED NONGOVERNMENTAL ORGANIZATIONS. THE SUMMIT WAS HELD IN CONJUNCTION WITH THE ADVANCED COURSE ON HIV PATHOGENESIS AT THE UNIVERSITYS SCHOOL OF MEDICINE. SPEAKERS INCLUDED AMFAR VICE PRESIDENT AND DIRECTOR OF RESEARCH DR. ROWENA JOHNSTON; DR. MARIO STEVENSON, A PROFESSOR OF MEDICINE AT THE UNIVERSITY OF MIAMIS MILLER SCHOOL OF MEDICINE; AND DR. ESPER KALLAS, AN INFECTIOUS DISEASE SPECIALIST AND A PROFESSOR AT THE UNIVERSITY OF SO PAULO SCHOOL OF MEDICINE. THINK TANKS CONSISTENT WITH AMFARS COMMITMENT TO INVESTIGATE EVERY AVENUE THAT MAY LEAD TO A CURE, THE FOUNDATION REGULARLY HOSTS THINK TANKS THAT BRING TOGETHER LEADING INVESTIGATORS IN VARIOUS FIELDS. IN OCTOBER 2016, AMFAR HOSTED A THINK TANK IN LISBON, PORTUGAL, TITLED "PROGRESS REPORT: RESEARCH TOWARD A CURE FOR AIDS IN THE CONTEXT OF ICISTEM." ICISTEM IS A CONSORTIUM OF 17 EUROPEAN RESEARCHES THAT AIMS TO REPLICATE THE CASE OF "THE BERLIN PATIENT." IT WAS CREATED AND IS FUNDED BY AMFAR THROUGH ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE. AMFAR HOSTED ANOTHER THINK TANK IN APRIL 2017 IN PALO ALTO, CA, ON STRATEGIES TO IDENTIFY LATENTLY INFECTED CELLS. THE RESEARCHERS DISCUSSED FINDING A BIOMARKER FOR THESE CELLS AS AN ALTERNATIVE APPROACH TO "SHOCK AND KILL." ONE OF THE BIGGEST CHALLENGES WITH THE "SHOCK-AND-KILL" STRATEGY IS THAT CURRENT DRUG REGIMENS DO NOT REAWAKEN ALL OF THE INFECTED CELLS. PROGRAM SERVICE ACCOMPLISHMENTS (2) LINE 4B: TREAT ASIA: AMFARS TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF TREATMENTS FOR HIV AND ITS CO-INFECTIONS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. TREAT ASIA SCIENTISTS PRODUCED A RECORD 35 PUBLICATIONS IN PEER-REVIEWED MEDICAL JOURNALS IN 2017. INTERNATIONAL AIDS DATABASE TREAT ASIA MANAGES THE ASIA-PACIFIC SECTION OF THE INTERNATIONAL EPIDEMIOLOGIC DATABASES TO EVALUATE AIDS (IEDEA), A GLOBAL COLLABORATION ESTABLISHED BY THE U.S. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. IN FY2017, THE IEDEA CONSORTIUM FUNDED THE SECOND YEAR OF STAY (STUDY OF TRANSITIONING ASIAN YOUTH), WHICH AIMS TO DOCUMENT THE EXPERIENCE OF HIV-INFECTED YOUNG ADULTS WHO ARE TRANSITIONING FROM PEDIATRIC TO ADULT CARE. TREAT ASIA HIV OBSERVATIONAL DATABASE (TAHOD) TREAT ASIA PIONEERED THE REGIONS FIRST ADULT OBSERVATIONAL DATABASE FOR HIV/AIDS, WHICH NOW INCLUDES ANONYMOUS DATA FROM APPROXIMATELY 9,200 PATIENTS AT 21 CLINICAL SITES IN 12 COUNTRIES. THE INFORMATION GATHERED IN THE DATABASE INFORMS THE DEVELOPMENT OF MORE EFFECTIVE RESEARCH AND TREATMENT PROGRAMS AND HELPS DEFINE TREATMENT STANDARDS SPECIFIC TO HIV/AIDS IN ASIA. TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) LAUNCHED IN 2014, TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) CONTAINS DATA FROM OVER 37,000 HIV-POSITIVE PATIENTS ACROSS 10 TREAT ASIA NETWORK SITES. AS AN EXTENSION OF TAHOD, TAHOD-LITE AIMS TO INCREASE THE SCOPE OF ADULT DATA COLLECTION BY GATHERING A SUBSET OF CORE VARIABLES FROM THE ENTIRE COHORT OF HIV-INFECTED PATIENTS WHO HAVE SOUGHT CARE AT SELECTED TAHOD SITES. TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) THE TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) IS A REGIONAL PEDIATRIC HIV STUDY SET UP BY TREAT ASIA IN 2006. IT WAS MODELED AFTER THE ADULT DATABASE AND INCLUDES DATA FROM MORE THAN 6,400 CHILDREN AND ADOLESCENTS AT 19 CLINICAL SITES IN CAMBODIA, INDIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM. ADDRESSING ADOLESCENT MENTAL HEALTH IN JANUARY 2017, TREAT ASIA ORGANIZED A THINK TANK IN BANGKOK ON ADOLESCENT MENTAL HEALTH, BRINGING TOGETHER REGIONAL INVESTIGATORS AND YOUTH ADVOCATES FROM CAMBODIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM TO DISCUSS HOW TO ADDRESS RESEARCH AND CLINICAL TRAINING GAPS. AS A RESULT OF THE DISCUSSION, TREAT ASIA IS EVALUATING THE PREVALENCE OF MENTAL HEALTH DISORDERS AMONG HIV-INFECTED ADOLESCENTS IN THE REGION AND DEVELOPING TRAININGS FOR PEDIATRIC HIV PROVIDERS ON MENTAL HEALTH MANAGEMENT.
PROGRAM SERVICE ACCOMPLISHMENTS (2) CONT.IN JUNE 2017, TREAT ASIA HOSTED A TRAINING IN BANGKOK TO HELP CLINICIANS BETTER DIAGNOSE AND MANAGE MENTAL HEALTH DISORDERS IN ADOLESCENTS LIVING WITH HIV. THE WORKSHOP BROUGHT TOGETHER MORE THAN 30 CLINICAL AND MENTAL HEALTH PROFESSIONALS WHO WORK WITH HIV-POSITIVE YOUTH IN THAILAND, CAMBODIA, INDONESIA, AND MALAYSIA. THE TRAINING REVIEWED THE EPIDEMIOLOGY OF ADOLESCENT MENTAL HEALTH ISSUES, MENTAL HEALTH NEEDS AMONG YOUTH LIVING WITH HIV, PSYCHOPHARMACOLOGY, AND SUICIDE RISK ASSESSMENT TOOLS. EMPOWERING YOUTH ADVOCATES IN JUNE 2017, THE FIRST CLASS OF TREAT ASIA'S YOUTH ACATA-ASIA COMMUNITY FOR AIDS TREATMENT AND ADVOCACY-HELD ITS FINAL WORKSHOP IN BANGKOK, WHERE EIGHT YOUNG PEOPLE LIVING WITH HIV FROM CAMBODIA, INDONESIA, AND THAILAND GRADUATED FROM THE TWO-YEAR LEADERSHIP TRAINING PROGRAM. LAUNCHED IN 2015 WITH SUPPORT FROM VIIV HEALTHCARES POSITIVE ACTION FOR ADOLESCENTS PROGRAM, YOUTH ACATA AIMS TO EDUCATE PARTICIPANTS ABOUT HIV AND ANTIRETROVIRAL THERAPY AND CONNECT THEM TO OTHER HIV-POSITIVE YOUTH IN THE REGION.THE REGION. HELPING ADOLESCENTS TRANSITION TO ADULT CARE IN FY2017, TREAT ASIA CONTINUED WORKING TO HELP ADOLESCENTS LIVING WITH HIV TRANSITION TO ADULT CARE. WITH FUNDING FROM AIDS LIFE AUSTRIA, THE PROGRAM PROVIDED A GRANT TO THE CHILDREN AND YOUTH PROGRAM OF SEARCH (SOUTH EAST ASIA RESEARCH COLLABORATION ON HIV) AT THE THAI RED CROSS AIDS RESEARCH CENTRE IN BANGKOK TO IMPLEMENT A TRANSITION MODEL THAT FOCUSES ON ISSUES SUCH AS MOVING TO ADULT CARE, COPING WITH NEGATIVE EMOTIONS, TREATMENT, AND STIGMA. ADVOCATING FOR CO-INFECTION TREATMENT ACCESS IN JUNE 2017, TREAT ASIA HELD ITS ANNUAL REGIONAL ADVOCACY MEETING ON HEPATITIS C, HIV, AND TUBERCULOSIS TREATMENT IN BANGKOK, WITH CIVIL SOCIETY ORGANIZATIONS, CLINICAL CARE PROFESSIONALS, AND INTELLECTUAL PROPERTY EXPERTS. DURING THE YEAR, TREAT ASIA ALSO ATTENDED AND PRESENTED AT SEVERAL CONFERENCES ON HEPATITIS C TREATMENT ACCESS AND PARTNERED WITH CIVIL SOCIETY GROUPS AND FUNDERS ON ADVOCACY EFFORTS. INTRODUCING PREP TO THE PHILIPPINES IN JULY 2017, ENROLLMENT BEGAN FOR A TWO-YEAR PILOT PROJECT THAT INTRODUCES ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS (PREP) TO THE PHILIPPINES IN AN EFFORT TO CURB THE RAPID SPREAD OF HIV INFECTION AMONG MEN WHO HAVE SEX WITH MEN (MSM) AND TRANSGENDER INDIVIDUALS. THE PROJECT, KNOWN AS PREPPY (PREP PILIPINAS), WILL EVALUATE COMMUNITY-BASED, PEER-DRIVEN DELIVERY OF PREP AT TWO CLINICS IN MANILA. AMFAR IS AMONG SEVERAL ORGANIZATIONS INVOLVED IN PROJECT PREPPY, A MULTIAGENCY COLLABORATION WITH EXPERTS FROM GOVERNMENT, ACADEMIA, AND MULTILATERAL AND NONGOVERNMENTAL ORGANIZATIONS. PUBLICATIONS IN NOVEMBER 2016, TREAT ASIA, IN CONJUNCTION WITH AMFARS PUBLIC POLICY OFFICE, PRODUCED A REPORT TITLED CERVICAL CANCER, HUMAN PAPILLOMAVIRUS (HPV), AND HPV VACCINES IN SOUTHEAST ASIA: KEY CONSIDERATIONS FOR EXPANDING VACCINE COVERAGE AND IMPROVING POPULATION HEALTH. THE REPORT DOCUMENTS THE SLOW UPTAKE OF HPV VACCINATION IN THE REGION AND GIVES RECOMMENDATIONS FOR INCREASING USE OF THE VACCINE. IN MARCH 2017, TREAT ASIA PRODUCED THE FACT SHEET PREP ACCEPTABILITY AMONG FEMALE SEX WORKERS IN THAILAND: KEY RESEARCH FINDINGS BASED ON A STUDY JOINTLY CONDUCTED BY THE INSTITUTE FOR POPULATION AND SOCIAL RESEARCH AT MAHIDOL UNIVERSITY IN BANGKOK, JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH IN BALTIMORE, AND THE COMMUNITY-BASED ORGANIZATION SERVICE WORKERS IN GROUP (SWING) FOUNDATION. HIV PREVALENCE AMONG THAI FEMALE SEX WORKERS IS SIGNIFICANTLY HIGHER THAN IN THE GENERAL POPULATION, AND ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS (PREP) MAY HELP REDUCE INFECTION RATES. IN SEPTEMBER 2017, TREAT ASIA CREATED THE FIRST IN A SERIES OF INFOGRAPHICS TITLED WHY HAS ASIA FALLEN BEHIND ON HIV/AIDS? TO ILLUSTRATE THE STAGNATION IN HIV PROGRAM COVERAGE IN THE ASIA-PACIFIC. THE STAGNATION IS A REMINDER TO GOVERNMENTS, CIVIL SOCIETY, AND DONORS THAT MUCH MORE NEEDS TO BE DONE TO BRING HIV/AIDS UNDER CONTROL IN THE REGION. IN ADDITION, TREAT ASIA CONTINUED TO PUBLISH LAY-LANGUAGE ARTICLES ON HIV/AIDS RESEARCH, POLICY, AND COMMUNITY ISSUES FACING THE ASIA-PACIFIC AS A WHOLE. THE ARTICLES AND EDUCATIONAL PIECES APPEAR IN THE TREAT ASIA REPORT, A BIMONTHLY E-NEWSLETTER, AND ON TREAT ASIAS WEBSITE, WWW.TREATASIA.ORG. 16TH ANNUAL NETWORK MEETING THE 2016 TREAT ASIA ANNUAL NETWORK MEETING WAS HELD IN OCTOBER 2016 IN HANOI, VIETNAM, WHERE MORE THAN 120 ADULT AND PEDIATRIC INVESTIGATORS, DONORS, AND PROGRAM PARTNERS GATHERED TO REVIEW PROGRESS ON THE NETWORKS RESEARCH AGENDA, HEAR ABOUT REGIONAL HIV-RELATED POLICY PRIORITIES, AND PLAN FOR FUTURE INITIATIVES. THE MEETING INCLUDED SPECIAL PRESENTATIONS ON A WIDE RANGE OF PROJECTS INCLUDING: - A PILOT PROGRAM INTRODUCING PRE-EXPOSURE PROPHYLAXIS (PREP) TO MEN WHO HAVE SEX WITH MEN AND TRANSGENDER INDIVIDUALS, A STUDY SUPPORTED BY AMFAR AND PRESENTED BY DR. ROSSANA DITANGCO OF THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE IN THE PHILIPPINES; - RESEARCH AND POLICY INITIATIVES TO FIGHT HIV, HEPATITIS C, AND SEXUALLY TRANSMITTED INFECTIONS IN THE ASIA-PACIFIC, PRESENTED BY DR. YING-RU LO OF THE WORLD HEALTH ORGANIZATIONS WESTERN PACIFIC REGIONAL OFFICE; AND - TREAT ASIA/INTERNATIONAL EPIDEMIOLOGIC DATABASES TO EVALUATE AIDS (IEDEA) ASIA-PACIFIC RESEARCH, PRESENTED BY DR. CAROLYN WILLIAMS OF THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. OTHER CONFERENCES TREAT ASIA STAFF AND NETWORK INVESTIGATORS ATTENDED AND PRESENTED AT SEVERAL REGIONAL AND INTERNATIONAL CONFERENCES ON HIV-RELATED ISSUES. EXAMPLES INCLUDE: IAS 2017 TREAT ASIA HAD A STRONG PRESENCE AT THE 9TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE IN PARIS IN JULY. DR. NITTAYA PHANUPHAK OF THE THAI RED CROSS AIDS RESEARCH CENTRE IN BANGKOK WAS ON THE EPIDEMIOLOGY AND PREVENTION RESEARCH PLANNING COMMITTEE, WHILE DR. ADEEBA KAMARULZAMAN OF THE UNIVERSITY OF MALAYA SERVED ON THE IMPLEMENTATION RESEARCH PLANNING COMMITTEE. IN ADDITION, DRS. KAMARULZAMAN, ANCHALEE AVIHINGSANON OF THE THAI RED CROSS AIDS RESEARCH CENTRE, AND ANETTE SOHN, DIRECTOR OF TREAT ASIA, CO-CHAIRED VARIOUS SESSIONS AND FACILITATED WORKSHOPS. SEVEN TREAT ASIA GRANTEES MADE PRESENTATIONS. APACC TREAT ASIA WAS ALSO WELL REPRESENTED AT THE SECOND ASIA PACIFIC AIDS & CO-INFECTIONS CONFERENCE (APACC), HELD JUNE 1-3, 2017, IN HONG KONG. APACC IS A REGIONAL-LEVEL HIV RESEARCH CONFERENCE THAT PROVIDES OPPORTUNITIES FOR LOCAL CLINICIANS, STUDENTS, AND RESEARCHERS TO SUBMIT ABSTRACTS FOR PRESENTATION. THE CO-CHAIRS INCLUDED TREAT ASIA DIRECTOR DR. ANNETTE SOHN AND CURRENT AND FORMER TREAT ASIA NETWORK INVESTIGATORS DRS. PATRICK CHUNG-KI LI, FORMERLY OF QUEEN ELIZABETH HOSPITAL IN HONG KONG, AND ADEEBA KAMARULZAMAN. PROGRAM SERVICE ACCOMPLISHMENTS (3) LINE 4C: PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT HIV-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. EDUCATIONAL MATERIALS AMFAR PRODUCES A RANGE OF PERIODICALS IN BOTH PRINT AND ELECTRONIC FORMATS, INCLUDING ITS NEWSLETTER INNOVATIONS, PUBLISHED TWICE A YEAR AND DISTRIBUTED TO MORE THAN 40,000 PEOPLE; THE TREAT ASIA REPORT, AN EMAIL NEWSLETTER DISTRIBUTED SIX TIMES A YEAR TO MORE THAN 4,000 READERS IN THE INTERNATIONAL HEALTH COMMUNITY; AND A MONTHLY E-MAIL NEWSLETTER DISTRIBUTED TO NEARLY 70,000 PEOPLE. THE FOUNDATIONS WEBSITES - WWW.AMFAR.ORG AND WWW.CURECOUNTDOWN.ORG - FEATURE NEWS, INTERVIEWS, AND ORIGINAL ARTICLES COVERING HIV RESEARCH, POLICY, THE GLOBAL EPIDEMIC, AND AMFAR PROGRAMS AND ACTIVITIES. THE WEBSITES ATTRACT A COMBINED AVERAGE OF 45,000 VISITORS PER MONTH. AMFAR ALSO CREATES AND DISTRIBUTES REPORTS, PRESS RELEASES, AND UPDATES ON MAJOR HIV/AIDS ISSUES AND CONDUCTS PUBLIC SERVICE ADVERTISING CAMPAIGNS THAT HAVE BEEN INSTRUMENTAL IN EDUCATING POLICYMAKERS, HEALTHCARE PROFESSIONALS, PEOPLE LIVING WITH HIV/AIDS, AND THE PUBLIC. EPIC VOICES IN JUNE 2017, AMFAR LAUNCHED EPIC VOICES, AN ONLINE VIDEO SERIES THAT AIMS TO REENERGIZE THE RESPONSE TO HIV AMONG MILLENNIAL AND LGBTQ COMMUNITIES. THE GOALS OF THE CAMPAIGN ARE TO: RENEW AWARENESS OF THE PERSISTENT THREAT OF HIV, UNDERSCORE THE URGENT NEED TO SUPPORT HIV RESEARCH, AND SUPPORT AMFARS LEADERSHIP IN THE SEARCH FOR A CURE. AMFAR SPOKE TO HIV ACTIVISTS ACROSS THE COUNTRY AND ASKED THEM TO SHARE THEIR UNIQUE JOURNEYS, THEIR INSIGHTS ON LIVING WITH HIV, AND THE BOLD STEPS THEY HAVE TAKEN IN THE FIGHT AGAINST THE EPIDEMIC.
PROGRAM SERVICE ACCOMPLISHMENTS (3) CONT.SOCIAL MEDIA AMFAR HAS VIGOROUSLY EXPANDED ITS PRESENCE IN THE SOCIAL MEDIA ARENA, REACHING LARGE NUMBERS OF PEOPLE, INCLUDING A YOUNGER DEMOGRAPHIC THAT IS OFTEN LESS EDUCATED ABOUT HIV AND THE AIDS EPIDEMIC. THE FOUNDATION REGULARLY ADDS CONTENT TO ITS FACEBOOK PAGE, LIVE TWEETS FROM EVENTS, AND POSTS IMAGES ON INSTAGRAM FROM FUNDRAISING AND PROGRAM EVENTS. AMFAR HAS 74,000 LIKES ON FACEBOOK, 43,000 TWITTER FOLLOWERS, AND MORE THAN 130,000 INSTAGRAM FOLLOWERS. MEDIA OUTREACH IN FY2017, AMFAR CONTINUED TO WORK CLOSELY WITH THE MEDIA TO RAISE THE PROFILE OF HIV/AIDS, BOTH DOMESTICALLY AND INTERNATIONALLY, AND TO HELP ENSURE THE ACCURACY OF HIV - RELATED PRESS COVERAGE. ARTICLES AND REPORTS INVOLVING AMFAR - MANY OF WHICH INCLUDED INTERVIEWS WITH STAFF - WERE CARRIED IN NUMEROUS MEDIA OUTLETS, INCLUDING THE NEW YORK TIMES, THE WASHINGTON POST, THE CHICAGO TRIBUNE, THE HILL, POLITICO, NBC NEWS, CBS NEWS, CNBC, U.S. NEWS & WORLD REPORT, REUTERS, EBONY, AND HUFFPOST. CELEBRITY SUPPORT AMFARS PUBLIC AWARENESS EFFORTS ARE GREATLY ENHANCED BY THE COMMITTED SUPPORT OF PUBLIC FIGURES WHO LEND THEIR VOICES AND DONATE THEIR TIME, TALENTS, AND RESOURCES TO HELP SUSTAIN THE FOUNDATIONS MISSION. SUPPORT OF AMFAR BY PROMINENT PUBLIC FIGURES BEGAN WITH THE LATE DAME ELIZABETH TAYLOR, AMFARS FOUNDING INTERNATIONAL CHAIRMAN, AND OTHERS HAVE FOLLOWED IN HER FOOTSTEPS. AMFAR IS PROFOUNDLY GRATEFUL FOR THE CONTINUING STEADFAST SUPPORT OF GLOBAL CAMPAIGN CHAIR SHARON STONE. OTHER CELEBRITY SUPPORTERS INCLUDED AMFAR AMBASSADORS MILLA JOVOVICH, MICHELLE YEOH, CHEYENNE JACKSON, AND LIZA MINNELLI, CHARLIZE THERON, ADRIEN BRODY, JESSICA CHASTAIN, MATT BOMER, DITA VON TEESE, GWYNETH PALTROW, DIANA ROSS, CHIARA FERRAGNI, DIANE KRUGER, IMAN, KATIE HOLMES, UMA THURMAN, KATE MOSS, ZAC POSEN, ZOE SALDANA, TOBEY MAGUIRE, DAME HELEN MIRREN, LEA MICHELE, MICHELLE RODRIGUEZ, WILL SMITH, NICOLE KIDMAN, NAOMI CAMPBELL, HEIDI KLUM, JON HAMM, EVA LONGORIA, LEONARDO DICAPRIO, ROBERT DE NIRO, NICKI MINAJ, ANDREA BOCELLI, DEAN AND DAN CATEN, CHRIS TUCKER, JENNIFER GARNER, SCARLETT JOHANSSON, DONATELLA VERSACE, VICTORIA JUSTICE, AND CARINE ROITFELD.AND CARINE ROITFELD. PROGRAM SERVICE ACCOMPLISHMENTS (4) LINE 4D: THE GMT INITIATIVE: IMPLEMENTATION SCIENCE AWARDS IN FY2017, AMFARS GRANT MAKING THROUGH THE GMT INITIATIVE SUPPORTED A TRIO OF LARGE IMPLEMENTATION SCIENCE PROJECTS AIMED AT IDENTIFYING BARRIERS TO HIV TESTING, TREATMENT, AND CARE AND STUDYING THE IMPACT OF INNOVATIVE HIV SERVICE DELIVERY MODELS FOR GAY MEN, OTHER MEN WHO HAVE SEX WITH MEN, AND TRANSGENDER INDIVIDUALS (COLLECTIVELY, GMT) IN LOW- AND MIDDLE-INCOME COUNTRIES. AMFAR HAS AWARDED $2.6 MILLION OVER THREE YEARS TO SUPPORT THE STUDIES. DR. CHRIS BEYRER OF JOHNS HOPKINS UNIVERSITY IN BALTIMORE IS LEADING A TEAM OF RESEARCHERS AND COMMUNITY-BASED SERVICES (IN COLLABORATION WITH THE INTERNATIONAL HIV/AIDS ALLIANCE MYANMAR) IN EVALUATING THE EFFECTIVENESS OF PROMISING INTERVENTIONS FOR GMT IN MYANMAR, WHERE INCREASED HIV TESTING AND TREATMENT OPPORTUNITIES ARE BECOMING AVAILABLE. THE RESEARCHERS ARE ASSESSING THE EFFECTIVENESS OF HIV SELF-TESTING DONE IN THE PRIVACY OF ONES HOME, POINT-OF-CARE CD4 TESTING, AND THE USE OF "PEER NAVIGATORS" FAMILIAR WITH THE LOCAL HEALTH SYSTEM TO HELP THOSE NEWLY DIAGNOSED GAIN ACCESS TO HIV TREATMENT AND CARE. IN LIMA, PERU, DR. JAVIER LAMA OF ASOCIACIN CIVIL IMPACTA SALUD Y EDUCACIN AND HIS TEAM ARE AIMING TO IMPROVE THE CONTINUUM OF CARE AMONG TRANSGENDER WOMEN BY USING AN INNOVATIVE MODEL THAT INTEGRATES HIV PREVENTION AND TREATMENT SERVICES WITH TRANSGENDER-AFFIRMING MEDICAL CARE. WORKING IN COLLABORATION WITH THE BOSTON-BASED FENWAY INSTITUTE AND TWO COMMUNITY GMT ORGANIZATIONS, LAMA AND HIS TEAM ARE INTEGRATING ROUTINE CROSS-SEX HORMONE THERAPY INTO HIV AND SEXUALLY TRANSMITTED INFECTION PREVENTION, TESTING, AND TREATMENT SERVICES AND IMPLEMENTING HEALTH SERVICES AND PEER CASE MANAGEMENT FOR 200 TRANSGENDER WOMEN. AND IN BANGKOK, DR. NITTAYA PHANUPHAK AND HER TEAM AT THE THAI RED CROSS AIDS RESEARCH CENTRE ARE WORKING TO SHOW HOW INNOVATIVE TECHNOLOGIES SUCH AS GMT-TARGETED WEBSITES USING ONLINE COUNSELING AND SUPPORT CAN BE UTILIZED TO INCREASE RATES OF HIV TESTING AND REFERRALS TO PREVENTION AND TREATMENT PROGRAMS. WORKING IN COLLABORATION WITH ADAMS LOVE, A WEB-BASED HEALTH PLATFORM FOR GMT INDIVIDUALS, AND TWO COMMUNITY-BASED ORGANIZATIONS (SERVICE WORKERS IN GROUP/SWING AND THE RAINBOW SKY ASSOCIATION OF THAILAND), THE TEAM IS COMPARING THE EFFECTIVENESS OF ONLINE SERVICES AND SUPPORT INTERVENTIONS WITH TRADITIONAL CLINIC-BASED HIV SERVICES, AND A HYBRID MODEL THAT COMBINES ELEMENTS OF BOTH STRATEGIES. PUBLICATIONS IN DECEMBER 2016, AMFAR AND THE UNIVERSITY OF PITTSBURGH PRODUCED A SUPPLEMENT TO THE JOURNAL AIDS AND BEHAVIOR DEVOTED TO THE HIV SCHOLARS PROGRAM AT THE UNIVERSITYS CENTER FOR LGBT HEALTH RESEARCH. THE AMFAR-FUNDED PROGRAM HAS SUPPORTED RESEARCH TRAINING FOR 16 YOUNG INVESTIGATORS FROM LOW- AND MIDDLE-INCOME COUNTRIES, AS WELL AS THEIR INDIVIDUAL RESEARCH PROJECTS FOCUSED ON HIV AND AIDS AMONG GMT. SCHOLARS HAVE COME FROM A WIDE RANGE OF COUNTRIES, INCLUDING PAKISTAN, CHINA, SOUTH AFRICA, LEBANON, AND BELIZE, AMONG OTHERS.
PROGRAM SERVICE ACCOMPLISHMENTS (5)LINE 4D: PUBLIC POLICY: INFORMED BY THOROUGH RESEARCH AND ANALYSIS, AMFAR IS A HIGHLY RESPECTED ADVOCATE OF RATIONAL AND COMPASSIONATE HIV/AIDS-RELATED PUBLIC POLICY. THE FOUNDATION IS ENGAGED IN EFFORTS TO SECURE NECESSARY INCREASES IN FUNDING FOR HIV/AIDS RESEARCH; IMPLEMENT THE U.S. NATIONAL HIV/AIDS STRATEGY; EXPAND ACCESS TO CARE AND TREATMENT; AND PROTECT THE CIVIL RIGHTS OF ALL PEOPLE AFFECTED BY HIV/AIDS. ENDING THE DOMESTIC HIV EPIDEMIC IN OCTOBER 2016, AMFAR PUBLISHED A REPORT THAT RECOMMENDS SEVERAL MEASURES HEALTH PLANS AND HEALTHCARE PURCHASERS, INCLUDING MEDICARE AND MEDICAID PROGRAMS AND PRIVATE INSURERS, CAN TAKE TO HELP END THE DOMESTIC HIV EPIDEMIC. CURBING THE HIV EPIDEMIC BY SUPPORTING EFFECTIVE ENGAGEMENT IN HIV CARE: RECOMMENDATIONS FOR HEALTH PLANS AND HEALTH CARE PURCHASERS OUTLINES ACTIONABLE STEPS TO IMPROVE HEALTH OUTCOMES, REDUCE UNNECESSARY SPENDING, AND CONTRIBUTE TO THE DEVELOPMENT OF MORE INTEGRATED SYSTEMS OF CARE FOR PEOPLE LIVING WITH HIV. IN NOVEMBER 2016, AMFAR, IN CONJUNCTION WITH TREATMENT ACTION GROUP, PUBLISHED A REPORT IN THE JOURNAL OF THE INTERNATIONAL AIDS SOCIETY PROPOSING A CONCEPTUAL FRAMEWORK FOR AN INTEGRATED PRIMARY AND SECONDARY HIV PREVENTION CONTINUUM FOR THE UNITED STATES. THE MODEL IS BASED ON THE WIDELY USED HIV CARE CONTINUUM, WHICH TRACKS THE PERCENTAGE OF THE POPULATION LIVING WITH HIV WHO ARE DIAGNOSED, TREATED, AND ULTIMATELY VIRALLY SUPPRESSED, AND FOCUSES ON THE REDUCTION OF HIV ACQUISITION THROUGH ENGAGEMENT IN HIV PREVENTION SERVICES. CAPITOL HILL BRIEFING IN JUNE 2017, GOVERNMENT OFFICIALS, SCIENTISTS, AND PUBLIC HEALTH LEADERS CONVENED AT THE AMFAR CAPITOL HILL CONFERENCE, "MAKING AIDS HISTORY: A ROADMAP FOR ENDING THE EPIDEMIC." THE CONFERENCE HIGHLIGHTED THE LATEST ADVANCES IN HIV PREVENTION, TREATMENT, AND RESEARCH AND ADDRESSED THE CHALLENGES THAT REMAIN IN ERADICATING THE VIRUS. SPEAKERS AND PANELISTS DISCUSSED THE NATIONAL SECURITY IMPLICATIONS OF EPIDEMICS, THE ECONOMIC AND HEALTH IMPACT OF AGING WITH HIV, AND THE OPIOID CRISIS AND ITS RELATIONSHIP TO HIV AND OTHER INFECTIOUS DISEASES. HIV AND THE OPIOID EPIDEMIC IN JUNE 2017, AMFAR LAUNCHED A COMPREHENSIVE ONLINE DATABASE TO HELP COMMUNITIES, POLICYMAKERS, AND ADVOCATES EFFECTIVELY RESPOND TO THE OPIOID EPIDEMIC. THE OPIOID & HEALTH INDICATORS DATABASE PROVIDES LOCAL AND NATIONAL STATISTICS ON HIV AND HEPATITIS C INFECTIONS, OPIOID USE, OVERDOSE DEATH RATES, AND THE AVAILABILITY OF SERVICES SUCH AS DRUG TREATMENT AND SYRINGE SERVICES PROGRAMS. AMFAR ALSO PUBLISHED AN ISSUE BRIEF OUTLINING THE CASE FOR SUPERVISED CONSUMPTION SERVICES (SCS), WHICH PROVIDE A HYGIENIC SPACE FOR PEOPLE TO USE ILLICIT DRUGS UNDER THE SUPERVISION OF TRAINED STAFF. THE FACILITIES ARE DESIGNED TO REDUCE THE RISK OF HIV/HEPATITIS C TRANSMISSION, PREVENT OVERDOSE FATALITIES, AND PROVIDE A BRIDGE TO TREATMENT AND OTHER SOCIAL SERVICES. SCS HAVE BEEN SHOWN TO LOWER RATES OF SYRINGE SHARING, REDUCE PUBLIC INJECTING, AND PROMOTE SAFER AND MORE HYGIENIC DRUG USE. GLOBAL HEALTH IN JANUARY 2017, AMFAR PUBLISHED A REPORT ARGUING THAT A CURE ALONE WILL NOT END THE HIV EPIDEMIC, AND THAT ONLY WITH A COORDINATED AND ENDURING COMMITMENT CAN ANY DISEASE BE CONTROLLED. USING TUBERCULOSIS AND MALARIA AS EXAMPLES, HOW CURES CAN FAIL SHOWS THAT GLOBAL EFFORTS TO ERADICATE WIDESPREAD DISEASES CAN FAIL EVEN WHEN EFFECTIVE CURES ARE AVAILABLE. DESPITE TUBERCULOSIS AND MALARIA BEING PREVENTABLE AND CURABLE, TWO MILLION PEOPLE DIE EVERY YEAR FROM THESE DISEASES. IN JUNE 2017, AMFAR PUBLISHED DERAILING PROGRESS: THE HUMAN IMPACT OF THE U.S. FY2018 GLOBAL HEALTH BUDGET, AN INFOGRAPHIC SHOWING THE IMPACT OF $800 MILLION IN PROPOSED CUTS TO THE U.S. PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) AND USAID IN FISCAL YEAR 2018, A 17% DECREASE. SUCH A SUBSTANTIAL DECREASE COULD CAUSE MORE THAN 1 MILLION HIV TREATMENT DISRUPTIONS FOR BOTH CHILDREN AND ADULTS, NEW HIV INFECTIONS, AND 146,000 PREVENTABLE AIDS-RELATED DEATHS. IN AUGUST 2017, AMFAR PUBLISHED AN ANALYSIS REVEALING THAT NATIONAL STRATEGIC PLANS (NSPS) ON HIV/AIDS FOR COUNTRIES IN SUB-SAHARAN AFRICA DO NOT CONSISTENTLY DISAGGREGATE HIV TARGETS BY SEX, OR CREATE TARGETS DESIGNED TO ADVANCE GENDER EQUALITY. NSPS ARE PLANNING DOCUMENTS THAT SET PRIORITIES AND TARGETS FOR A COUNTRYS RESPONSE TO THE HIV EPIDEMIC. THE REPORT WAS PUBLISHED IN THE JOURNAL HEALTH POLICY AND PLANNING. AMFAR ALSO PUBLISHED AN ISSUE BRIEF OUTLINING THE POTENTIAL IMPACT OF THE MEXICO CITY POLICY (MCP) ON GLOBAL AIDS FUNDING. MCP HAS HISTORICALLY PROHIBITED U.S. FAMILY PLANNING FUNDING FOR NON-U.S. NONGOVERNMENTAL ORGANIZATIONS PERFORMING OR PROMOTING ABORTION. PRESIDENT REAGAN INTRODUCED THE MEASURE IN 1984 AND IT HAS GONE BACK AND FORTH EVER SINCE. AFTER BEING REPEALED BY PRESIDENT OBAMA, THE POLICY HAS BEEN REVIVED AND EXPANDED BY THE TRUMP ADMINISTRATION. IAS 2017 AMFARS PUBLIC POLICY OFFICE PARTICIPATED IN THE 9TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE (IAS 2017) IN PARIS IN JULY. THE OFFICE CO-SPONSORED A TWO-HOUR SATELLITE SESSION, WITH FHI 360/LINKAGES, USAID, AND THE CDC, TITLED "BETTER DATA, BETTER PROGRAMMES: HOW IMPLEMENTATION SCIENCE IS TRANSFORMING THE HIV RESPONSE FOR KEY POPULATION." THE SEMINAR FEATURED TWO AMFAR-FUNDED STUDIES: "GENDER-AFFIRAMATIVE TRANSGENDER CARE TO IMPROVE THE HIV TREATMENT CASCADE" BY DR. JAVIER LAMA OF ASOCIACION CIVIL IMPACTA SALUD Y EDUCACION (IMPACTA) IN LIMA, PERU AND "COMMUNITY-BASED AND ONLINE STRATEGIES FOR TESTING, TREATMENT AND PREP AMONG MSM AND TRANSGENDER PERSONS IN THAILAND" BY DR. NITTAYA PHANUPHAK OF THE THAI RED CROSS AIDS RESEARCH CENTRE IN BANKOK. ALSO AT THE CONFERENCE, AMFAR POLICY ASSOCIATE JENNIFER SHERWOOD PRESENTED A POSTER TITLED "HIV RISK FACTORS AND ASSOCIATED HEALTH OUTCOMES AMONG SEXUAL MINORITY WOMEN IN THE THE UNITED STATES. "HER COLLEAGUE, POLICY ASSOCIATE ALANA SHARP, PRESENTED TWO POSTERS: "QUALITY ASSESSMENT OF NATIONAL STRATEGIC PLAN TARGETS"GLOBAL FUND FUNDING TRANSITION READINESS IN THE MIDDLE-INCOME COUNTRIES". IN THE NEWS IN MARCH 2017, AMFAR SENIOR POLICY AND MEDICAL ADVISOR DR. SUSAN BLUMENTHAL PENNED AN OP-ED FOR NATIONAL WOMEN AND GIRLS HIV/AIDS AWARENESS DAY WARNING OF THE IMPLICATIONS OF REPEALING THE AFFORDABLE CARE ACT AND LIMITING ACCESS TO HEALTHCARE. SHE WROTE THAT SUCH ACTION COULD RESULT IN A POTENTIAL RESURGENCE OF HIV INFECTION IN THE U.S., JEOPARDIZE THE LIVES OF PEOPLE WITH HIV, AND REVERSE THE STRIDES THAT HAVE BEEN MADE TO EFFECTIVELY PREVENT AND TREAT THE DISEASE. THE OP-ED WAS PUBLISHED ON THE ADVOCATE AND HUFFPOST. IN JUNE 2017, GREG MILLETT, AMFARS VICE PRESIDENT AND DIRECTOR OF PUBLIC POLICY, WAS WIDELY QUOTED IN A NEW YORK TIMES MAGAZINE ARTICLE TITLED "AMERICA'S HIDDEN H.I.V. EPIDEMIC: WHY DO AMERICA'S BLACK GAY AND BISEXUAL MEN HAVE A HIGHER H.I.V. RATE THAT ANY COUNTRY IN THE WORLD?" THE PIECE FOCUSED ON JACKSON, MS, WHICH HAS THE NATIONS HIGHEST RATE OF GAY AND BISEXUAL MEN (40%) LIVING WITH HIV. ALSO IN JUNE, AMFAR POLICY ASSOCIATE ALANA SHARP AND DR. RAHUL GUPTA, PUBLIC HEALTH COMMISSIONER AND STATE HEALTH OFFICER FOR WEST VIRGINIA, PUBLISHED AN OPINION PIECE IN THE HILL ON THE IMPACT OF PROPOSED CUTS TO THE CDC AND MEDICAID ON EFFORTS TO COMBAT THE OPIOID EPIDEMIC. WEST VIRGINIA HAS THE HIGHEST DRUG-RELATED DEATH RATE IN THE COUNTRY. IN ADDITION, A 2016 CDC ASSESSMENT FOUND THAT 50% OF THE STATE WAS AT HIGH RISK FOR HIV AND HEPATITIS C OUTBREAKS CAUSED BY THE SHARING OF NEEDLES.
POLICIESFORM 990, PART VI, SECTION B LINE 11 - THE FORM 990 WAS PREPARED BY A NATIONALLY RENOWNED ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. A COPY OF THE DRAFT FORM 990 WAS CIRCULATED TO THE FULL BOARD OF TRUSTEES FOR DISCUSSION AND COMMENT. EACH BOARD MEMBER WAS PROVIDED AMPLE OPPORTUNITY TO COMMENT ON THE INFORMATION CONTAINED IN THE 990 PRIOR TO ITS FILING WITH THE INTERNAL REVENUE SERVICE. LINE 12 - EACH OFFICER, DIRECTOR, TRUSTEE AND KEY EMPLOYEE OF AMFAR ("FOUNDATION") IS REQUIRED TO ANNUALLY DISCLOSE ANY CONFLICTS OF INTEREST THAT ARISE BY VIRTUE OF EMPLOYMENT, BOARD SERVICE, OR POSITION WITH THE FOUNDATION. THE FOUNDATION MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY THROUGH AN ANNUAL QUESTIONNAIRE/DISCLOSURE STATEMENT THAT IS DISTRIBUTED TO THESE INDIVIDUALS. POTENTIAL CONFLICTS ARE INVESTIGATED IMMEDIATELY. LINE 15 - AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS.
DISCLOSUREFORM 990, PART VI, SECTION C LINE 19 - AMFAR MAKES ITS FORM 990 AVAILABLE TO THE PUBLIC BY RETAINING A COPY AT ITS PLACE OF BUSINESS AND ON ITS WEBSITE, WWW.AMFAR.ORG. THE FORM 990 IS LIKEWISE PUBLISHED ON THE INTERNET AT WWW.GUIDESTAR.ORG. THE FOUNDATION'S FINANCIAL STATEMENTS ARE MADE AVAILABLE IN ITS ANNUAL REPORT AND ON ITS WEBSITE. THE FOUNDATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT ORDINARILY MADE AVAILABLE TO THE PUBLIC, BUT, IF REQUESTED, WILL BE PROVIDED AT MANAGEMENT'S DISCRETION.
FUNCTIONAL EXPENSESPART IX, LINES 1 & 3 THE FOUNDATION FOR AIDS RESEARCH REPORTS ITS GRANTS NET OF GRANT RETURNS OR RECOVERIES. PERIODICALLY, GRANTS REMITTED TO CHARITABLE ORGANIZATIONS ARE RETURNED TO AMFAR FOR A VARIETY OF REASONS. ON SCHEDULES F & I, GRANTS ARE REPORTED IRRESPECTIVE OF WHETHER THEY WERE ULTIMATELY RETURNED TO AMFAR SINCE CATEGORIZING THE "RETURNED" AMOUNTS WOULD BE TIME CONSUMING. THEREFORE, AMOUNTS REPORTED ON PART IX, LINE 1 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE I; AMOUNTS REPORTED ON PART IX, LINE 3 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE F.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.